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ABSTRACT 
(ENGLISH VERSION) 
 
The co-transcription factors YAP/TAZ are potent inducers of tissue and organ 
growth during development and tissue regeneration after damage. In this work we 
have expanded on the repertoire of YAP/TAZ regulations and on their biological 
properties. We found that these are regulated by the mechanical properties of the 
microenvironement and by the Wnt signaling cascade. The latter is induced by 
mutations in the tumor suppressor APC, a hallmark of intestinal cancer, and here 
we show that this is accompanied by YAP/TAZ stabilization and is functional for 
transformation of intestinal cells. Both the mechanical and Wnt regulations have 
been published (Azzolin et al., 2014; Aragona et al., 2013). Aberrant YAP/TAZ 
activation is known to be associated to tissue overgrowth, tumorigenesis and 
acquisition of cancer stem cell traits. Here we explore the role of YAP/TAZ as 
key factors in somatic stem cell self-renewal and somatic cell plasticity 
(unpublished).  
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ABSTRACT 
(ITALIAN VERSION) 
 
I co-fattori di trascrizione YAP/TAZ sono potenti induttori di espansione tissutale 
durante lo sviluppo embrionale e la rigenerazione dei tessuti. In questo lavoro 
abbiamo ampliato lo studio del repertorio di regolazioni di YAP/TAZ e il loro 
ruolo biologico. Abbiamo scoperto che YAP/TAZ sono regolati dalle proprietà 
meccaniche del microambiente cellulare e dalla cascata di segnale di Wnt. 
Quest’ultima è indotta da mutazioni a carico dell’oncosoppressore APC, un 
elemento caratteristico dei tumori intestinali. In questo studio, dimostriamo che la 
mutazione di APC è accompagnata dalla stabilizzazione di YAP/TAZ e che 
questo evento è funzionale alla trasformazione delle cellule intestinali. Le 
regolazioni di YAP/TAZ, da parte di stimoli meccanici e tramite la via di 
trasduzione di Wnt, sono trattate in lavori pubblicati (Aragona et al., 2013; 
Azzolin et al., 2014). L’attivazione anomala di YAP/TAZ è associata a iperplasia, 
tumorigenesi e acquisizione di caratteristiche tipiche di cellule staminali tumorali. 
In questo lavoro esploriamo il ruolo di YAP/TAZ come fattori essenziali per 
l’auto-rinnovamento di cellule staminali somatiche e per la plasticità cellulare 
(non pubblicato). 
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EXTENDED ABSTRACT 		
The co-transcription factors YAP/TAZ are potent inducers of tissue and organ 
growth during development and tissue regeneration after damage. In this work we 
have expanded on the repertoire of YAP/TAZ regulations and on their biological 
properties. We found that these are regulated by the mechanical properties of the 
microenvironement and by the Wnt signaling cascade. The latter is induced by 
mutations in the tumor suppressor APC, a hallmark of intestinal cancer, and here 
we show that this is accompanied by YAP/TAZ stabilization and is functional for 
transformation of intestinal cells. Aberrant YAP/TAZ activation is associated to 
tissue overgrowth, tumorigenesis and acquisition of cancer stem cell traits. It is 
tempting to speculate that YAP/TAZ might be key factors involved in the 
maintenance or the acquisition of the somatic SC state whenever natural, 
pathological or ex vivo conditions demand de novo generation and expansion of 
resident or facultative SCs. Indeed, we found that YAP/TAZ are pivotal factors 
genetically required for the expansion of somatic stem cells ex vivo, at least for 
three different paradigmatic cases: the intestinal epithelium, the exocrine pancreas 
and the central nervous system. The prospect to induce autologous, tissue-specific 
somatic stem cells in vitro is an important goal for regenerative medicine and 
disease modeling. Here we show that expression of a single factor, YAP, into 
terminally differentiated cells explanted from different tissues efficiently creates 
cells with functional and molecular attributes of their corresponding tissue-
specific SCs, that can be expanded ex vivo as organoid cultures (ySCs). The ySC 
state can be transmitted through cell generations without need of continuous 
expression of ectopic YAP/TAZ, indicating that a transient activation of YAP is 
sufficient to induce a heritable self-renewing state. In particular, this treatment 
stably converts murine terminally differentiated pancreatic exocrine cells into 
pancreatic duct-like progenitors and brain neurons into neural SCs. Thus the same 
factor induces distinct tissue-specific SCs through cell reprogramming. If 
extended to human cells, the present findings would represent a generally 
applicable procedure to generate in vitro a variety of normal, tissue-reconstituting 
autologous SCs at will. 
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INTRODUCTION 
 
Stem cells (SCs) display the capacity to renew themselves when they divide, and 
to generate a differentiated progeny. Somatic SCs operate in multiple adult organs 
for continuous tissue renewal or repair after injury. Yet, these cells are still mainly 
defined by operational definitions and cell surface markers rather than the 
molecular traits that govern their special status (Fuchs and Chen, 2013). 
Unlimited availability of normal, somatic SCs will be critical for effective organ 
repopulation in regenerative medicine applications, to understand SC biology and 
for disease modeling in the Petri dish. These efforts are frustrated by the fact that 
SCs are rare and difficult to purify from native tissues or to expand ex vivo. A 
recent groundbreaking step forward in this direction has been the description of 
culture systems allowing adult epithelial SCs of endodermal origin to expand and 
self-organize into "organoids" (Sato et al., 2009). Yet, these protocols still require 
the isolation of native SCs as starting material. 
Direct conversion of terminally differentiated cells back into their corresponding 
tissue-specific SCs may represent an attractive alternative to obtain somatic SCs. 
Stemness and differentiation are not hierarchically fixed states defined only by 
intrinsic cellular properties, but rather inherently plastic and interchangeable 
states, greatly influenced by extrinsic cues operating at the tissue level. Indeed, 
several reports have recently highlighted a surprising plasticity in somatic cell 
fates, as differentiated cells can return to a SC status under special conditions, 
such as tissue damage (Blanpain and Fuchs, 2014).  
However, the identity of the factors able to control the somatic SC status remains 
poorly understood, limiting the exploitation of such plasticity. YAP/TAZ have 
been portrayed as stemness factors (reviewed in Ramos and Camargo, 2012) and 
indeed these factors are strictly required whenever somatic stem cells need to be 
amplified for tissue regeneration after damage or in the case of aberrant growth 
triggered by oncogenic transformation. It is thus tempting to speculate that 
YAP/TAZ might be key factors involved in the maintenance or the acquisition of 
the somatic SC state whenever natural, pathological or ex-vivo conditions demand 
de novo generation and expansion of resident or facultative SCs. 
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YAP/TAZ regulations 
 
Hippo signaling 
 
Recently, the Hippo signaling cascade has emerged at the center of mechanisms 
that control tissue growth and organ size (Pan, 2010) providing an entry point to 
tackle the long-standing issue of how organs can control their size and shape 
during development or regeneration.   
The core elements in Hippo signaling, which constitute an intracellular signal 
transduction kinase cascade, were first discovered in Drosophila genetic 
screenings for tumor suppressor genes, identifying four key components (Pan, 
2010; Ramos and Camargo, 2012): the protein kinase Hippo -after which the 
signaling pathway is named - and its partner Salvador, the NDR family protein 
kinase Warts, and its adaptor protein Mob-as-tumor-suppressor (Mats).  
These discoveries in Drosophila led to the investigation of Hippo signaling also in 
mammals, revealing several conserved aspects of the pathway. The mammalian 
genome harbors two Hippo homologs, MST1 and MST2, one Salvador homolog, 
known as SAV1, two Warts homologs, LATS1 and LATS2, and two Mats 
homologs, collectively referred to as MOB1 (see scheme in Figure 1A). 
Importantly, several loss-of-function mutant phenotypes in Drosophila can be 
rescued by the re-expression of their respective human homologs. 
 
The Hippo intracellular kinase cascade leads to inactivation of the transcriptional 
co-factors YAP and TAZ 
 
At the core of the mammalian Hippo signaling cascade are the kinases MST1/2 
and LATS1/2 (Figure 1A) (reviewed in Pan, 2010; Ramos and Camargo, 2012): 
activated MST1/2 directly phosphorylate the large tumor suppressor kinases 
LATS1 and LATS2, as well as MOB1, allowing the formation of a stable 
LATS1/2-MOB1 complex. Hippo signaling-dependent transcriptional responses 
are mediated by two transcriptional co-factors: YAP (Yes-associated protein) and 
TAZ (transcriptional co-activator with PDZ-binding motif), also known as 
WWTR1. Activated LATS1/2 phosphorylate YAP at Ser127 and TAZ at Ser89, 
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promoting binding to 14-3-3 proteins. This leads to cytoplasmic retention and 
reduced nuclear accumulation of these factors. In addition, phosphorylation can 
also inhibit YAP and TAZ by promoting their degradation through ubiquitination 
and proteasomal pathway (see scheme in Figure 1A). Phosphorylation of a 
specific HXRXXS motif at S381 by LATS1/2 primes YAP for subsequent 
phosphorylation by CK1δ/ε, followed by the recognition by the E3 ubiquitin 
ligase SCFβ-TrCP and ubiquitin-mediated degradation of YAP. Both S381 and S127 
are critical for YAP inactivation by the hippo pathway, because only a YAP 
isoform carrying mutations at both sites, but not YAP wild-type or YAP carrying 
single mutations is able to transform NIH 3T3 cells (Zhao et al., 2010). The S381 
phosphodegron of YAP is conserved in TAZ; phosphorylation of TAZ S311 by 
LATS primes the protein for subsequent phosphorylation on S314 by CK1ε and 
recruitment of the SCFβ-TrCP E3 ubiquitin ligase, thus leading to TAZ 
ubiquitylation and degradation (Liu et al., 2010). Collectively, phosphorylation 
clearly inactivates YAP and TAZ-dependent transcriptional responses. 
When YAP/TAZ escape this control (i.e., when LATS is inhibited), they localize 
to the nucleus where they serve as co-activators of different DNA-binding factors, 
such as p73, Runx2, PPAR-γ, thyroid transcription factor1, Pax3 and the TEA-
domain family members TEAD1/2/3/4. YAP and TAZ are transcriptional 
activators devoid of a DNA binding domain and thus require the association with 
a DNA-binding partner to activate the transcription of their target genes. Among 
DNA-binding co-factors, the TEAD family of transcription factors, which are 
homologs of Drosophila Scalloped, are the most relevant mediators of YAP and 
TAZ function (Zanconato et al., 2015; Zhang et al., 2009; Zhao et al., 2008). 
Together, the YAP/TAZ-TEAD complex promotes proliferative and survival 
programs by inducing the expression of a genetic program that is just beginning to 
be explored.  
 
Upstream elements in Hippo signaling 
 
Although the signal transduction within the core kinase cascade is well defined, 
the mechanisms and proteins involved in upstream regulation of the Hippo 
pathway are not as well established (reviewed in Pan, 2010; Piccolo et al., 2014; 
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Ramos and Camargo, 2012). The mammalian genome contains homologs of a 
number of Drosophila upstream regulators of the Hippo pathway, including two 
homologs of the cytoskeleton binding proteins Expanded (FRMD6 and FRMD1) 
and Merlin (NF2/Mer), and two homologs of their interacting partner Kibra 
(KIBRA/WWC1 and WWC2).  
Merlin/NF2 is localized at the cell membrane of confluent monolayers of 
epithelial cells, where it is suggested to exert its tumor-suppressive function by 
promoting the correct protein assembly for LATS activation by phosphorylation 
(Yin et al., 2013; Yu et al., 2010) (see Scheme in Figure 1A). Indeed, 
reconstitution of Merlin in the NF2-deficient MDA-MB-231 cell line leads to a 
strong, LATS-dependent inhibition of YAP/TAZ activity (Aragona et al., 2013). 
Epithelial architecture has been shown to be a relevant regulator of YAP/TAZ 
activity; the baso-lateral polarity protein Scribble promotes the assembly of a 
MST-LATS-TAZ complex at the membrane, required for LATS activation and 
TAZ inhibition (see scheme in Figure 1A). The disruption of epithelial 
architecture and epithelial-to-mesenchymal transition is a hallmark of cancer and 
leads to delocalization of Scribble and TAZ activation (Cordenonsi et al., 2011).  
Recently, YAP/TAZ and angiomotin (AMOT) family proteins were shown to 
interact, resulting in YAP/TAZ localization to tight junctions and inhibition 
through phosphorylation-dependent and independent mechanisms (Chan et al., 
2011; Mana-Capelli et al., 2014). Other evidence, however, showed that at least in 
some conditions, as in the context of NF2 deficiency, AMOTs can function also 
as YAP activators (Kim et al., 2011; Schlegelmilch et al., 2011; Yi et al., 2013). 
In addition, α-catenin loss was shown to induce a potent activation of  YAP 
activity in keratinocytes, by a mechanism that entails a decrease in YAP-
phosphorylation, possibly through the modulation of a kinase different from 
LATS (Kim et al., 2011). The diverse modalities of Hippo pathway activation 
argue for the notion that the adhesive properties of the cell are of central 
importance for the modulation of YAP/TAZ activity through the Hippo pathway. 
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The biological roles of Hippo signaling 
 
Overexpression of YAP/TAZ or mutation of diverse components of the Hippo 
pathway leads to the development of hugely overgrown organs, due to the 
increase in mitosis and to decreased susceptibility to cell death (reviewed in 
Halder and Johnson, 2011; Piccolo et al., 2014; Zhao et al., 2010) portraying 
Hippo signaling as a fundamental regulator of organ size. For instance, 
overexpression of the YAP/TAZ orthologue Yorkie in Drosophila results in a 
massive enlargement of the eye and of the wing imaginal discs (Figures 1B-C) 
(Dong et al., 2007; Huang et al., 2005). Strikingly similar phenotypic effects are 
observed in mammals; conditional knockout of the Hippo pathway component 
Salvador leads to cardiomegaly (Figure 1D) (Heallen et al., 2011) and YAP 
overexpression results in massive liver overgrowth in transgenic mice (Figure 1E) 
(Dong et al., 2007). Different studies show that two general physiological roles of 
Hippo signaling are the promotion of cellular quiescence and of cellular 
differentiation (reviewed in Piccolo et al., 2014; Ramos and Camargo, 2012). As 
will be detailed below, conditional mutants for Hippo pathway components result 
in expansion of the progenitor cell compartment of diverse organs and tissues. 
This is consistent with in vitro evidence, whereby YAP hyperactivation leads to 
failure of cell cycle exit and terminal differentiation.  
The Hippo nuclear transducers also play a prominent role in the phenomenon of 
cell contact inhibition. When scratch wounds are generated in confluent cell 
cultures to relieve contact inhibition, YAP nuclear localization is significantly 
elevated in cells at the border of the wound, while cells further away show 
cytoplasmic localization of YAP (Zhao et al., 2007). Importantly, cells 
experiencing YAP nuclear localization are also positive for Ki67, a marker of cell 
proliferation, indicating that these cells have re-entered the cell division cycle. It 
must however be noted, as will be discussed below, that more recent evidence has 
shown that for overt growth arrest and quantitative YAP/TAZ nuclear exclusion 
to occur, a mechanical inhibitory step must take place, whereby cells undergo 
contact inhibition of proliferation when cell projected area drops below a defined 
size, due to progressive cell crowding (Aragona et al., 2013). 
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All these sets of evidence indicate a role for Hippo signaling in balancing cell 
proliferation and differentiation in different contexts.  
YAP and TAZ in mechanotransduction 
 
In addition to the aforementioned regulations, YAP and TAZ can respond to a 
variety of stimuli, as hinted by the recent discovery that they are regulated by 
extra-cellular matrix (ECM) stiffness, cell shape and cytoskeletal tension (Dupont 
et al., 2011; reviewed in Halder et al., 2012). When cells are cultured on stiff 
substrates TAZ and YAP are nuclear and can induce the expression of their target 
genes; conversely, if cells are grown on soft substrates, YAP and TAZ are re-
localized to the cytoplasm and thus inactivated. Intriguingly, one set of data 
suggests that mechanical signals regulate YAP and TAZ through a pathway that 
acts in parallel to the classic kinase cascade of the Hippo pathway, as knockdown 
of LATS1 and LATS2 was not sufficient to restore YAP and TAZ activity in cells 
cultured on soft extra-cellular matrix (Dupont et al., 2011). Crucially, YAP and 
TAZ are the key mediators of the biological effects of ECM stiffness and cell 
shape. For example, endothelial cells die when forced to remain small, whereas 
they proliferate when allowed to spread, and the levels of YAP and TAZ dictate 
these opposite behaviors: if YAP and TAZ are artificially increased in small cells, 
these start to proliferate; in contrast, attenuation of YAP and TAZ in spread cells 
causes them to die (Dupont et al., 2011).  
Regulation by Rho GTPases 
 
YAP/TAZ activity can also be influenced by Rho-GTPases. The first evidence in 
this direction came from the observation that YAP/TAZ are potently inhibited by 
treatment with the Clostridium botulinum toxin C3 (Dupont et al., 2011), a known 
Rho-GTPase inhibitor. In addition, a number of G-protein coupled receptors 
(GPCRs) have been shown to signal through YAP/TAZ (Yu et al., 2012). Recent 
studies found that the metabolic pathway triggered by the mevalonate/HMG-CoA 
reductase is instrumental in supporting YAP/TAZ activity, as some byproducts of 
the mevalonate cascade are essential to sustain the activity of Rho-GTPases at cell 
membranes (Sorrentino et al., 2014; Wang et al., 2014).  
	 17	
Some results suggest that the Rho and cytoskeletal pathway are formally distinct, 
as Rho regulates YAP through phosphorylation, while the mechanotransduction 
pathway impinges on YAP/TAZ activity in a phosphorylation-independent 
manner. Thus, the relationship between Rho GTPases and the actin cytoskeleton 
remains an open question in the field of YAP/TAZ regulations.  
 
YAP/TAZ role in tissue and organ growth 
 
Germ line knockouts 
 
In Drosophila the loss of Hippo pathway components or of F-actin inhibitors 
results in tissue overgrowth, and the YAP/TAZ orthologue Yorkie is required for 
cell proliferation in several embryonic tissues (Fernandez et al., 2011; 
Hamaratoglu et al., 2006; Harvey and Tapon, 2007; Justice et al., 1995; Maitra et 
al., 2006; Sansores-Garcia et al., 2011; Tapon et al., 2002). This function is 
conserved in mammals; indeed YAP transgenic mice display extensive cell 
proliferation and tissue overgrowth (Camargo et al., 2007; Dong et al., 2007). 
Germ line knockouts of the Hippo pathway components NF2, MST1/2, and 
LATS2 are lethal at relatively early embryonic stages: Nf2-/- and Mst1/2-/- caused 
impaired development of the extraembryonic tissues (McClatchey et al., 1997; 
McPherson et al., 2004; Zhou et al., 2009). 
Yap/Taz double null mutants die before embryo implantation (Nishioka et al., 
2009). Yap-/- embryos die shortly after gastrulation, at stage E8.5 (Morin-Kensicki 
et al., 2006). These embryos show some similarities to the phenotype observed in 
double Tead1/2 knockout embryos, where the axial mesoderm is not maintained 
(Sawada et al., 2008). Taz knockouts display high rates of embryonic lethality, but 
a fraction of Taz mutants develop to term and die of polycystic kidney disease and 
pulmonary emphysema (Hossain et al., 2007; Makita et al., 2008). 
Immunofluorescence at the morula stage shows that YAP and TAZ are localized 
in the nucleus of trophoectoderm (TE) cells, while inner cell mass (ICM) cells 
display cytoplasmic YAP/TAZ. Overexpression of activated forms of YAP or 
TEAD, or inactivation of LATS1/2, is sufficient to induce expression of the TE 
master gene Cdx2 in ICM; conversely, LATS2 overexpression suppresses Cdx2 
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expression in TE (Nishioka et al., 2009). These findings suggest a role for 
YAP/TAZ activity as inhibitors of embryonic pluripotency and crucial regulators 
of the development of TE. 		
Conditional knockouts 
 
Conditional knockout alleles and inducible transgenic mice suggested some key 
functions of YAP/TAZ and Hippo signaling in organ growth, cell proliferation, 
stem cell amplification, and cell fate decision in organs and tissues as diverse as 
liver (Camargo et al., 2007; Yimlamai et al., 2014; Zhou et al., 2009), kidney 
(Hossain et al., 2007; Reginensi et al., 2013), heart (Heallen et al., 2011; Xin et 
al., 2013), pancreas (Gao et al., 2013; George et al., 2012), intestinal epithelium 
(Cai et al., 2010; Lee et al., 2008; Zhou et al., 2011), epidermis (Schlegelmilch et 
al., 2011; Zhang et al., 2011) and the nervous system (Lavado et al., 2013).  
Nuclear YAP is endogenously restricted to intestinal progenitor cells at the 
bottom of intestinal crypts, as shown by immunohistochemical stainings (Barry et 
al., 2013). YAP overexpression in transgenic mice enhances intestinal cell 
proliferation and impairs differentiation (Camargo et al., 2007). YAP/TAZ are 
required for intestinal epithelium regeneration after inflammatory damage, but are 
dispensable form normal intestinal homeostasis (Cai et al., 2010; Azzolin et al., 
2014). 
In contrast to what is observed for other organs, such as in the case of the liver 
(Camargo et al., 2007; Yimlamai et al., 2014; Zhou et al., 2009), conditional 
deletion of the Hippo pathway components MST1/2 in the pancreas does not 
result in organ overgrowth, but rather in a reduction of organ size. (Gao et al., 
2013; George et al., 2012). Ductal cells of Mst1/2 knockout pancreata were shown 
to maintain a proliferative status throughout adult life, in accordance with 
increased YAP activity. Importantly, deletion of one single allele of Yap in Mst1/2 
double knockout tissue was sufficient to rescue these phenotypes. In line with this 
evidence, overexpression of a constitutively active YAP mutant caused the 
expansion of ductal cells with the loss of acinar structures. Notably, again arguing 
in favor of the notion that YAP/TAZ are dispensable for normal tissue 
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homeostasis, pancreatic tissue remains histologically normal after homozygous 
deletion of YAP in the adult pancreas (Zhang et al., 2014).  
YAP has been implicated also in the regulation of brain development. Loss of the 
Hippo pathway upstream regulator NF2 in the dorsal telencephalon of transgenic 
mice leads to brain malformations characterized by aberrant expansion of neural 
progenitor cells in the hippocampus, neocortex and cortical hem. In line, the 
overexpression of transgenic YAP leads to alterations of the hippocampus similar 
to those observed in NF2 mutant brains, while the NF2-loss phenotype is rescued 
by concomitant YAP depletion, arguing in favor of a prominent role of YAP in 
this context (Lavado et al., 2013). Again, similarly to what described above for 
other organs, YAP inactivation per se has no detectable phenotypic consequences 
(Lavado et al., 2013). 
 
YAP/TAZ and Stem cells 
  
Emerging evidence suggests that the determination of organ size by YAP/TAZ 
could involve the regulation of stem cells and progenitor cells self-renewal and 
expansion reviewed in (Ramos and Camargo, 2012; Zhao et al., 2010). For 
instance, YAP and TAZ were reported to regulate human and mouse embryonic 
stem cells self-renewal in response to TGFβ/BMP (transforming growth factor 
beta/bone morphogenetic protein) signaling (Varelas et al., 2008). Additionally, as 
mentioned above, the Hippo pathway also regulates tissue-specific progenitor 
cells. YAP is specifically expressed in the intestinal crypt stem cell compartment 
(Barry et al., 2013), where overexpression of a LATS1/2-insensitive YAP mutant 
results in reversible expansion of undifferentiated cells (Camargo et al., 2007). 
Moreover, YAP/TAZ have been implicated in the control of the expansion of 
progenitor cells in the epidermis and in the liver in transgenic mouse models and 
of neural progenitors in mouse, frog and chick neural tubes (Schlegelmilch et al., 
2011; Silvis et al., 2011; Zhang et al., 2011; Benhamouche et al., 2010; Lee et al., 
2010; Song et al., 2009; Zhang et al., 2010; Zhou et al., 2009; Lavado et al., 2013; 
Cao et al., 2008; Gee et al., 2011). Of note, the fact that YAP/TAZ are stabilized 
and act in stem and progenitor cells, typically lodged in specific tissue niches 
(Ramos and Camargo, 2012), suggests that the ECM, the cell’s cytoskeletal 
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organization, and ensuing tensional forces may impart physical instructions that 
regulate stem cells behavior through a mechanotransduction-YAP/TAZ pathway.  
Recently YAP and TAZ have also been indicated as inductors of cancer stem cells 
in malignant glioma and in breast cancer (Bhat et al., 2011; Cordenonsi et al., 
2011). It was demonstrated that TAZ is required for the tumor-initiation capacities 
of breast cancer cells, as assayed by the capacity of cells to grow as 
mammospheres and to form tumors once injected at limiting dilutions in immuno-
compromised mice. Gain of TAZ endows tumor-initiating capacity to non-cancer-
stem-cells populations and loss of TAZ impairs this capacity in cancer-stem-cell-
enriched populations (Cordenonsi et al., 2011). In parallel with this, TAZ protein 
levels are found elevated in poorly differentiated human primary breast cancer, as 
assayed by immunohistochemistry analysis. Significantly, loss of TAZ impairs 
invasiveness, self-renewal and tumorigenic potential also in primary glioblastoma 
stem cells (Bhat et al., 2011).  
However, the emerging perception of YAP/TAZ as “stemness factors” (reviewed 
in Ramos and Camargo, 2012) is mainly based on two distinct pieces of evidence 
that remain so far poorly connected, as interpretations are hampered by the 
paucity of double YAP/TAZ knockout studies.  This notion is in fact mainly 
supported by the organ overgrowth phenotypes induced by Hippo mutants or YAP 
transgenic overexpression in the embryo and the preferential localization of 
YAP/TAZ proteins in cells belonging to the stem cell compartment of adult 
organs.  
The mechanism of action of YAP/TAZ during embryonic growth is still 
unexplored and, at the same time, the possible connection between somatic, 
tissue-specific stem cells and embryonic progenitors remains elusive and debated. 
As detailed above data based on conditional genetic inactivation of YAP in adult 
organs, such as pancreas and liver, and double knockout of YAP and TAZ in the 
intestine, show that YAP/TAZ activity is largely dispensable for normal tissue 
homeostasis. Still, YAP and TAZ are essential in any condition in which stem 
cells need to be amplified for tissue regeneration or after oncogenic 
transformation (Azzolin et al., 2014; Zhang et al., 2010; Zhang et al., 2014). This 
evidence argues in favor of the notion that YAP/TAZ might regulate stem cells 
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only when these are stimulated by specific intrinsic or extrinsic cues that drive 
their expansion. 
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AIMS AND WORKING HYPOTHESES 
 
 
Here we aimed to get deeper insights on the regulation and biology of YAP/TAZ. 
Part of this work is published and relates to the regulation by secreted factors and 
mechanical signals. We started by the observation that inactivation of the β-
catenin destruction complex stabilizes YAP/TAZ, and our own prior work 
(Azzolin et al., 2012) and continued to demonstrate the role of YAP/TAZ 
downstream of APC inactivation and in cultured intestinal organoids. We also 
took advantage of prior work (Dupont et al., 2011) to demonstrate that increasing 
intracellular biomechanical tension and changing the cell’s cytoskeletal 
organization are very potent regulators of YAP/TAZ. As for the so far 
unpublished part of this thesis, we were attracted by the fact that dysregulation of 
the Hippo signaling pathway has been recently associated with cellular 
dedifferentiation in some contexts. In tumors, the activation of the Hippo pathway 
transcriptional effectors YAP/TAZ can reprogram non-stem cancer cells into less-
differentiated cancer SCs (Cordenonsi et al., 2011). Genetic inactivation of the 
Hippo cascade in the liver induces the formation of a massive organ, in part 
through transient lineage conversion of hepatocytes into biliary cells (Yimlamai et 
al., 2014). Irrespectively of their complex roles in normal and aberrant tissues (as 
detailed in Introduction), this scenario raises the distinct possibility that ectopic 
expression of YAP or TAZ may be sufficient to turn any cell, even a normal 
differentiated cell, into a somatic SC.  
Here we first tested the relevance of YAP/TAZ to maintain the somatic stem cell 
status, employing ex vivo cultures of somatic progenitor cells derived from 
different organs as a model reminiscent of in vivo conditions in which stem cell 
expansion is called into action. Secondly, we tested the hypothesis, based on their 
capacity to reprogram non-stem cancer cells into cancer SCs (Cordenonsi et al., 
2011), that the transcriptional regulators YAP/TAZ may bestow stemness 
characteristics to normal differentiated cells, turning the latter into their 
corresponding, tissue-specifc somatic stem cells. We tested this hypothesis in two 
paradigm cell types of terminal differentiation, pancreatic exocrine acinar cells 
and neurons. 
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RESULTS 
 
YAP/TAZ regulation by cell density and tissue 
architecture 
 
YAP and TAZ inactivation underlies contact inhibition of proliferation (CIP), a 
classic paradigm of epithelial biology, defined by an arrest of cell divisions when 
cells become confluent and occupy the entire available space for their growth. 
This phenomenon recapitulates the growth-arrested condition of most epithelia 
when these reach their appropriate size and loss of this control mechanism is 
considered one of the hallmarks of cancer. Hippo pathway has been reported to be 
activated during the process of contact inhibition, as phosphorylation of YAP at 
S127 increases at the onset of CIP (Zhao et al., 2007). However, some evidence 
suggests that this regulation might be more complex, as combined MST1/2 
knockouts in mouse embryonic fibroblasts showed that regulation by the Hippo 
pathway is dispensable for CIP in that system (Schlegelmilch et al., 2011).  
In our recent work, we proposed a two-step model of YAP/TAZ regulation for 
CIP (Aragona et al., 2013). When cells engage in cell-cell contacts, the E-
cadherin/catenin system leads to LATS activation and YAP/TAZ 
phosphorylation. This, however, contributes for only 30% of growth inhibition 
and YAP/TAZ cytoplasmic re-localization. For overt growth arrest and 
quantitative YAP/TAZ nuclear exclusion to occur, a mechanical inhibitory step 
must take place: as cells proliferate, cell crowding in a monolayer progressively 
forces individual cells into smaller areas; in turn this impairs the YAP/TAZ 
mechanical pathway in a way reminiscent of YAP/TAZ inhibition in isolated 
single cells plated on small ECM islands or soft ECM. Indeed, by plating 
epithelial cells at different densities we found that overt growth arrest and 
YAP/TAZ inhibition occurs only in densely packed cells, as compared to 
confluent or sparse conditions (Figures 2A-C). YAP/TAZ inhibition by cell 
crowding and ensuing growth arrest closely resemble that observed in cells forced 
to acquire a small projected area by seeding on confined adhesive areas, as 
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compared to cells allowed to spread on un-patterned substrate (Figures 2D-E). We 
could in fact show that contact inhibition of proliferation occurs through 
mechanical cues impinging on YAP/TAZ activity; by employing a monolayer 
stretching device we found that stretching of a densely packed monolayer, which 
results in an increase of cell projected area, is sufficient to rapidly reactivate 
YAP/TAZ, as monitored by nuclear localization, and cause cells to re-enter S-
phase (Figures 2F-G). 
By a loss-of-function screening for known F-actin inhibitors we found that 
YAP/TAZ inhibition entails the remodeling of the F-actin cytoskeleton mediated 
by the F-actin capping and severing proteins Cofilin, CapZ, and Gelsolin (Figures 
2H-I). These proteins thus give rise to a mechanotransduction pathway that, 
through YAP/TAZ regulation, represents a tissue-level checkpoint for mammalian 
epithelial sheets. This also provides a means by which cells perceive the 
architectural topology of a tissue as patterns of local mechanical stresses, 
translating into different levels of YAP/TAZ activity that in turn pattern cell 
proliferation (Figure 2J). Of note, we could also show that the regulation of 
YAP/TAZ by cell mechanics is not only distinct from Hippo pathway-induced 
YAP/TAZ inhibition but, in fact, dominates over it. Remarkably, LATS1/2 
inactivation is per se inconsequential in cells experiencing a low mechanical stress 
(Figure 2J) (Aragona et al., 2013). Moreover, depletion of F-actin-
capping/severing proteins sustains YAP/TAZ activity without affecting their 
phosphorylation. In fact, LATS-mediated inhibition of YAP/TAZ requires a 
mechanically competent cytoskeleton, as the effect of LATS knockdown becomes 
manifest only in the absence of F-actin-capping/severing proteins (Figure 2J). In 
addition to the Hippo pathway, we found that mechanical cues also dominate the 
cellular response to soluble cues positively affecting YAP and TAZ activity. 
YAP/TAZ activation by WNT (see below) or GPCR signaling  requires a 
mechanically stressed cytoskeleton or, in cells experiencing a soft ECM or 
contact-inhibited, inactivation of F-actin capping and severing proteins (Figure 
2J) (Aragona et al., 2013).  
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Crosstalk between YAP/TAZ and WNT signaling 
 
YAP/TAZ can also respond to ligands of the Wnt family, a class of soluble 
growth factors implicated in the regulation of cell proliferation, stem cell 
expansion and tumorigenesis (Clevers, 2006; Niehrs and Acebron, 2012). 
Recently a body of work, carried on by us and other groups, revealed a deep 
integration of YAP/TAZ in the canonical Wnt pathway (Azzolin et al., 2014; 
Azzolin et al., 2012; Imajo et al., 2012). In particular, we found that stimulation 
by ligands of the canonical Wnt pathway, such as Wnt3A, results in nuclear 
accumulation of YAP/TAZ and triggers YAP/TAZ transcriptional activity 
(Figures 3A-C). Mechanistically, in absence of Wnt signaling, YAP/TAZ are 
components of the cytoplasmic β-catenin destruction complex, as revealed by co-
immunoprecipitation assays for the central scaffold component of complex Axin1 
(Figure 3D) (Azzolin et al., 2014). The β-catenin destruction complex is the core 
component of the canonical Wnt pathway, composed by a central scaffold protein, 
Axin, that coordinates other factors, such as adenomatous polyposis coli (APC), 
CK1, and glycogen synthase kinase-3 (GSK3).  Inside the β-catenin destruction 
complex β-catenin is phosphorylated by GSK3 and ubiquitinated by β-TrCP, 
leading to its subsequent proteasomal degradation. Wnt ligand stimulation causes 
the inactivation of the destruction complex by recruitment to the LRP6 co-
receptor, allowing β-catenin accumulation and activation of β-catenin-TCF/Lef 
transcriptional functions (Clevers, 2006). We found that Wnt stimulation also 
causes concomitant release of YAP/TAZ from the complex, allowing for their 
nuclear accumulation (Figure 3D). In line, depletion of destruction complex 
components, such as APC or Axin1/2, induces YAP and TAZ nuclear 
accumulation and is sufficient to trigger YAP/TAZ transcriptional activity in 
absence of Wnt stimulation (Figures 3E-G). By exploring the composition of the 
β-catenin destruction complex using co-immunoprecipitation assays we also 
uncovered an essential role of YAP/TAZ for the inhibition of β-catenin in Wnt-off 
state. The presence of YAP/TAZ in the complex is essential for recruitment of β-
TrCP, and thus for β-catenin inhibition in absence of Wnt signaling, as siRNA 
mediated depletion of YAP/TAZ impaired association of β-TrCP to the 
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destruction complex and resulted in the activation of β-catenin transcriptional 
activity (Figures 3H-I) (Azzolin et al., 2014). By freeing YAP/TAZ from the 
destruction complex, Wnt stimulation also releases β-catenin from ubiquitination, 
leading to its nuclear accumulation. By this mechanism, Wnt stimulation can 
concomitantly trigger activation of both β-catenin and YAP/TAZ in a coordinated 
fashion (see scheme in Figure 3J).  
We could illustrate a remarkable example of the biological roles of YAP/TAZ as 
transducers of the Wnt pathway in the intestinal epithelium. The homeostasis of 
this tissue depends on stem cells located at the bottom of the intestinal crypts, 
whose maintenance depends on Wnt signaling. YAP/TAZ activity is dispensable 
for Wnt-dependent intestinal homeostasis, as intestinal specific double knockout 
of YAP and TAZ is apparently inconsequential for normal intestinal physiology 
(Figure 3K) (Azzolin et al., 2014). Still, we found that YAP/TAZ are genetically 
required for intestinal crypts overgrowth triggered by aberrant Wnt signaling upon 
inactivation of the tumor suppressor APC (Figure 3K) (Azzolin et al., 2014). This 
result is also in line with the requirement of YAP/TAZ for regeneration of the 
intestinal epithelium after inflammatory damage (Cai et al., 2010). These results 
hint to the possibility that β-catenin and YAP/TAZ transcriptional programs may 
mediate distinct outcomes of Wnt signaling, with β-catenin/TCF being 
responsible for the control of normal homeostasis and YAP/TAZ being activated 
in conditions in which intense intestinal proliferation is required, such as 
tumorigenesis and regeneration. 
 
YAP/TAZ are required for self-renewal of somatic stem 
cells ex vivo 
 
Intestinal crypt cultures 
 
We first assessed the role of YAP/TAZ in the most established ex vivo culture 
system for somatic stem cells of endodermal origin: intestinal crypt cells. For this 
we first monitored the expression of endogenous YAP and TAZ by western 
blotting in dissected crypts and villi from the small intestine of adult mice. As 
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shown in Figure 4A, both YAP and TAZ are specifically expressed in the crypt 
compartment. These results are consistent with a recent report on YAP 
immunolocalization in the stem cells located at the crypt base (Barry et al., 2013). 
Inactivation of both YAP and TAZ in the intestinal epithelium has no effects on 
normal tissue homeostasis (Figure 3K) (Azzolin et al., 2014). However, 
YAP/TAZ are required for regeneration of the intestinal epithelium, as lack of 
YAP impairs crypt repopulation after injury (Cai et al., 2010). Moreover, 
combined deletion of YAP and TAZ rescues intestinal crypt hyperplasia caused 
by aberrant activation of the Wnt pathway after APC depletion (Figure 3K) 
(Azzolin et al., 2014). 
We thus sought to assess the combined relevance of YAP and TAZ for crypt 
regeneration ex vivo. For this, we focused on the growth of explanted intestinal 
crypts into budding organoids, as this represents a well-defined experimental 
system reminiscent of in vivo regeneration (de Lau et al., 2011). We cultured ex 
vivo intestinal crypts explanted from the small intestine (Sato et al., 2009) from 
control Villin-CreERT2 mice or from mice carrying double YAP/TAZ conditional 
alleles (Villin-CreERT2; Yapfl/fl; Tazfl/fl) and then seeded in Matrigel with a 
cocktail of supplements, including the Wnt-agonist R-Spondin, which is essential 
for crypt maintenance and growth. Control explants formed organoids irrespective 
of the presence or absence of tamoxifen. Remarkably, tamoxifen-induced deletion 
of YAP/TAZ blocked crypt growth and led to the demise of the mutant crypts 
(Figures 4B, C and D), revealing the essential role of YAP/TAZ in this process. 
 
Pancreatic progenitor cultures 
 
As a second paradigm of somatic progenitor cells, we focused on pancreatic 
progenitors purified from the pancreatic duct, that have been recently shown to be 
expandable in vitro (Huch et al., 2013).  
We explanted primary pancreatic duct fragments from pancreata of adult mice and 
cultured them as progenitor cultures in three-dimensional organoid culture 
conditions (Figure 5A).  
We found that, in contrast to primary acinar cells, pancreatic progenitors display 
nuclear YAP/TAZ, as shown by immunofluorescence (Figure 5B). In line with 
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this evidence, pancreatic progenitors display elevated YAP/TAZ activity 
compared to primary acinar cells, as measured by qRT-PCR for a number of 
endogenous YAP/TAZ targets, as Ctgf, AnkrD1, AmotL2 and Axl (Figure 5C).  
We thus asked whether, similarly to intestinal crypt organoids, pancreatic 
progenitor cultures genetically required YAP/TAZ for their propagation as 
organoids. For this, we derived pancreatic progenitor cultures from wild-type (wt) 
or from double conditional Yapfl/fl;Tazfl/fl mice and then excised the conditional 
alleles by transduction of Cre recombinase (or GFP as control) using adenoviral 
vectors (Adeno-Cre or Adeno-GFP) on these cultures upon passaging. Control 
progenitor cells (wt) formed organoids in the presence or absence of Adeno-Cre. 
Remarkably, combined deletion of YAP/TAZ severely inhibited organoid 
formation and led to the demise of all the mutant cells, revealing the essential role 
of YAP/TAZ for the self-renewal of pancreatic progenitors (Figures 3D and E).  
 
Neural stem cells 
 
As third paradigm of somatic stem cells we studied neural stem cells. We started 
by comparing YAP/TAZ activity in neural stem cells and in terminally 
differentiated neurons. For this, we prepared neurons by dissociating the 
hippocampus or cortex of late mouse embryos (E19), and selected for post-mitotic 
neurons by culturing primary cells in neuronal-differentiation medium containing 
AraC for 7 days (Han et al., 2008). This procedure eliminates proliferating cells, 
resulting in a population of mature post-mitotic neurons (>95%) displaying 
multiple neurites and expressing βIII-Tubulin (TuJ1), NeuN and other typical 
neuronal markers (see below and Figures 10B and 13C). In parallel, we also 
derived primary neural SCs (NSCs) from dissociated cerebral hemispheres; as 
previously reported (Palmer et al., 1997), NSCs formed floating neurospheres that 
could be passaged multiple times.  
By immunofluorescence, endogenous YAP and TAZ proteins were highly 
expressed and localized in the nucleus of Nestin-positive NSCs, but absent in 
TuJ1-positve neurons (Figure 6A). Consistently, YAP/TAZ target genes were 
specifically upregulated in NSCs, as measured by qRT-PCR on YAP/TAZ 
endogenous target genes Axl, Cyr61 and AmotL2 (Figure 6B). In light of the 
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results obtained with intestinal crypts and pancreatic progenitors, we thus asked if 
YAP/TAZ activity was instrumental for the propagation of NSCs in ex vivo 
cultures. For this, we derived neural stem cells from the brain of wt or 
Yapfl/fl;Tazfl/fl mice and transduced these cells with Adeno-Cre to excise YAP/TAZ 
conditional alleles. Remarkably, combined deletion of YAP/TAZ blocked 
neurosphere formation, while control (wt) NSCs formed neurospheres also in the 
presence of Adeno-Cre (Figure 6C). We thus conclude that YAP/TAZ are the 
essential endogenous factors that are required for the self-renewal/expansion ex 
vivo of somatic progenitor cells from a number of different tissues, namely the 
epithelia of the intestine and of the pancreas, and the nervous tissue of the brain.  
 
Ex vivo generation of pancreatic progenitors from 
exocrine cells 
 
Starting from the observed requirement of YAP/TAZ for the maintenance of 
progenitor cells in ex vivo conditions, we next asked whether these factors might 
also be sufficient to endow stem properties to more differentiated cells. More in 
detail, we asked whether a transient pulse of YAP expression could be sufficient 
to convert explanted differentiated pancreatic acinar cells into normal ductal 
progenitors. To this end, we dissociated the pancreas of R26-rtTA; tetOYAPS127A 
adult mice to obtain a highly pure preparation of exocrine acini (see Figure 9A for 
validation of differentiation markers expression in these explants). We embedded 
whole pancreatic acini explanted from R26-rtTA; tetOYAPS127A pancreata in 
collagen and cultured them in low serum, that is, under conditions known to 
preserve acinar cell identity ex-vivo (Means et al., 2005) (see experimental outline 
in Figure 7A). When treated with doxycycline to induce YAP expression, 
pancreatic acini converted within few days to ductal organoid structures, and with 
high efficiency (> 70%) (Figures 7B and D). As control, acini lacking YAP 
expression (e.g., left without doxycycline, see Figure 7 D), remained as such for 
over 2 weeks and never converted to ducts. After transferring to 100% 
Matrigel/pancreatic organoid medium, the YAP-induced ducts, but not control 
acini, regrew into organoids. After initial derivation, YAP-induced organoids (or 
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“yDucts”) could be passaged for several months even in absence of doxycycline 
and thus in absence of exogenous YAP/TAZ (for at least 10 passages, i.e. 6 
months) (Figure 7C). By morphology, size and growth pattern, organoids derived 
from converted acinar cells were comparable to those obtained from handpicked 
pancreatic duct fragments after whole pancreas dissociation (Huch et al., 2013) 
(compare Figure 5A, rightmost panel, with Figure 7C).  
 
Validation of acinar cell reprogramming by genetic lineage tracing  
 
To validate that yDucts were indeed derived from differentiated exocrine acinar 
cells, we carried out genetic lineage tracing experiments using Ptf1a-CreERTM; 
R26-LSL-rtTA-IRES-EGFP; tetO-YAPS127A mice. In the Ptf1a-CreERTM; R26-
LSL-rtTA-IRES-EGFP background, tamoxifen treatment of adult mice causes 
irreversible genetic tracing exclusively of pancreatic acinar cells (Pan et al., 
2013). After treatment, mice were kept without tamoxifen for 1 week and then 
pancreata were explanted to prepare whole acini, that were cultured as above (see 
experimental outline in Figure 8A).  As expected, with this genetic lineage tracing 
setup organoids derived from endogenous ductal progenitors explanted from 
Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP; tetO-YAPS127A pancreata were not 
labeled (Figure 8B), while pancreatic acinar cells were irreversibly labeled by 
EGFP (Figure 8C). These EGFP-positive cells never formed any organoid in 
absence of doxycycline (Figure 8C). Instead, doxycycline-induced YAP 
expression caused formation of expandable yDucts that retained EGFP positivity 
over passaging, formally demonstrating their derivation from terminally 
differentiated exocrine cells (Figures 8D,E).  
 
Characterization of the early steps of YAP-induced conversion of exocrine 
cells 
 
In order to have a deeper understanding of the YAP-induced conversion process, 
we also performed a time-course analysis of gene-expression dynamics occurring 
at the single cell level during reprogramming induced by tetO-Yap. As shown in 
Figure 8F, at the beginning of the experiment explanted cells expressed exocrine 
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markers (Amy and Ptf1a) but not markers of pancreatic progenitors (Pdx1, Sox9, 
K19, Car2), cell proliferation (CyclinD1) or the YAP targets Ctgf and cMyc 
(Zanconato et al., 2015). After 2 days of doxycycline treatment, pancreatic 
progenitor markers were turned on in most cells, and did so more robustly at day 
4 and very homogeneously in yDuct cells. At day 2 and day 4, but not in yDucts, 
most acinar cells retained concomitant expression of acinar markers, and could be 
thus considered as cells caught in transition. Interestingly, Nestin, an embryonic 
pancreatic progenitor marker (Delacour et al., 2004; Esni et al., 2004), is also 
turned on only in these reprogramming intermediates, being absent in both 
differentiated cells and yDucts. We further noticed that progenitor markers are 
already present at day 2, before cells acquire expression of the proliferation 
marker CyclinD1. 
Characterization of yDucts 	
yDuct-derived organoids are composed by an epithelial monolayer surrounding a 
central cavity (Figure 9B), a structure closely reminiscent of that one of organoids 
formed by endogenous pancreatic progenitors in culture (Huch et al., 2013). We 
then sought to characterize yDucts more deeply at the molecular level, in order to 
evaluate to what extent they are endowed of features associated to bona-fide 
pancreatic progenitors. For this, we compared the expression of exocrine 
differentiation versus ductal progenitor markers in primary pancreatic acini, 
yDucts and pancreatic progenitor cultures (Ducts). By qRT-PCR and 
immunofluorescence, YAP-induced organoids lost markers of exocrine 
differentiation (Ptf1a, α-amylase, Elastase, and CPA1) and acquired expression 
of ductal markers (K19, Sox9, Hes1, Cd44) and proliferative markers (cMyc and 
CyclinD1), all to levels comparable to those of native ductal organoids (Figures 
9A and B). To determine the extent of YAP-induced conversion of acinar cells, 
and their molecular overlap with native ductal progenitors, we carried out 
transcriptomic analyses. As shown in Figure 9C, yDucts diverged profoundly 
from parental acinar cells to become overtly similar to bona-fide pancreatic 
progenitors. 
Moreover, when placed in differentiating conditions, yDuct-derived cells could be 
induced to re-express the differentiated exocrine marker CPA1 and to 
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downregulate K19 (Figure 9D). When transplanted into the pancreas of NOD-
SCID mice, yDucts remained as such, and never formed any tumor (n=6, data not 
shown) indicating that yDucts are indeed non-transformed and non tumorigenic. 
Together, the results indicate that exocrine cells with a history of exposure to 
YAP acquired key molecular and biological features of ductal pancreatic 
progenitors 
 
YAP expression turns neurons into NSC-like cells 
 
As a second model of YAP-induced reprograming of differentiated cells we 
focused on neurons. Neurons are post-mitotic cells that have long been considered 
refractory to any cell fate change. The evidence above described, showing that 
YAP/TAZ are nuclearly localized and active in NSCs, but not in neurons, and that 
YAP/TAZ are genetically required for the expansion of NSCs in culture (see 
Figure 6), prompted us to verify whether ectopic expression of YAP in neurons 
was sufficient to convert them into NSCs.  
For this we prepared neurons by dissociating the hippocampus or cortex of late 
mouse embryos (E19) or newborns, and selected for post-mitotic neurons by 
culturing primary cells in neuronal-differentiation medium containing AraC for 7 
days in order to eliminate proliferating cells. These primary cultures were the 
starting cells of our reprogramming efforts and were validated as post-mitotic 
neurons as follows: i) our primary neurons displayed multiple neurites marked by 
bIII-Tubulin (TuJ1) and Tau and were extensively decorated by the synaptic 
marker Synaptophysin (Figure 6A and Figure 10A); ii) neurons also expressed 
NeuN and were negative for NSC/progenitor markers, such as Nestin, Sox2, 
Vimentin (Figure 13A); iii) by qRT-PCR and transcriptomic analyses, neurons 
expressed a number of late differentiation genes but lacked of NSC-associated 
markers (Figures 13B and C) (see expression of Syn1, Snap25, a-synuclein, 
CamK2a, Synaptotagmin, Synaptophysin and many others (see a full list in Table 
1).  
In order to test whether YAP could revert post-mitotic neurons to a NSC-like 
state, primary cells were infected with lentiviral vectors encoding for rtTA and 
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inducible wild-type YAP (see Experimental procedures). After AraC treatment, 
neurons were shifted to NSC medium in the presence of doxycycline (see 
experimental outline in Figure 10B). Remarkably, after 2 weeks, neurosphere-like 
structures emerged from YAP-expressing neurons (P0-spheres), but never from 
neurons transduced with rtTA alone, or rtTA combined with EGFP, empty vectors 
or transcriptionally inactive YAPS94A (Figure 10C). P0-spheres were then 
transferred to new plates for further growth, and could be then propagated for 
several passages as clonal outgrowths after single cell dissociation, 
indistinguishably from and at comparable frequency of native NSCs (Figure 10D). 
Of note, the propagation of YAP-induced NSCs (hereafter called yNSCs) as 
neurospheres did not require addition of doxycycline, indicating that transient 
exposure to exogenous YAP is sufficient to induce self-renewal properties that are 
autonomously maintained.  
 
Validation of neuronal reprogramming by genetic lineage tracing  
 
To validate that yNSCs derived from terminally differentiated neurons, we 
repeated YAP-induced reprograming starting from genetically lineage-traced 
neurons (see scheme in Figure 11A).  
For this, we employed the most established transgenic mouse strain used to 
genetically label exclusively post-mitotic neurons starting from late 
embryogenesis (Zhu et al., 2001), that is Syn1-Cre mice. These mice express the 
Cre recombinase under the control of the neuronal-specific Synapsin1 promoter; 
we crossed this strain with the conditional reporter line R26-CAG-LSL-tdTomato. 
We derived neurons form the brain of Syn1-Cre; R26-CAG-LSL-tdTomato 
transgenic mice and confirmed by immunofluorescence analyses that in our 
primary neuronal cultures expression of the lineage tracer (tdTomato) is indeed 
restricted to post-mitotic neurons, all displaying unambiguous neuronal 
morphology and expressing TuJ1 (in 100% of tdTomato-positive cells, n=635), 
Tau (100%, n=140) and NeuN (90%, n=252). None of these genetically-traced 
cells was ever positive for the neural stem cell markers Nestin, Vimentin, Mash1, 
or for proliferation markers (EdU; Ki67) (0%, n>4000 cells) (see figures 11B and 
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C). All labeled cells were also characterized by extensive dendritic processes, 
punctuated by the synaptic markers Synaptophysin and SV2A (Figure 11D).  
Moreover, in order to exclude the possibility that Syn1-Cre and might be expressed 
in rare or quiescent NSC contaminating our neuronal cultures, we also derived NSCs 
from Syn1-Cre; R26-CAG-LSL-tdTomato brains and found that, oppositely to 
neurons of the same genotypes, in no case we could detect lineage labeled 
neurospheres (0% over n>160 spheres obtained) (Figure 12A, bottom panels). 
Importantly, upon YAP-induced reprogramming, lineage-traced neurons from the 
brain of Syn1-Cre; R26-CAG-LSL-tdTomato transgenic mice gave rise to tdTomato-
positive neurospheres (Figure 12A). In contrast, as mentioned above, NSCs derived 
from the same strain were invariably unlabeled (Figure 12A, bottom left panel), 
confirming that these drivers are not active in natural NSCs and thus that yNSCs 
originated from differentiated neurons rather than through amplification of pre-
existing, contaminating progenitors. All lineage-traced yNSCs could be passaged for 
several generations (Figure 12A, bottom panels). This lineage-tracing setup also 
allowed us to follow YAP reprogramming of neurons explanted from Syn1-Cre; 
R26-CAG-LSL-tdTomato mice over several days with continuous imaging. YAP 
expression was specifically associated to a discrete set of sequential events (Figure 
12A, top panels): after 24/48 hours of doxycycline addition and switch to NSC 
medium, lineage-traced neurons started to lose neurites and flattened, acquiring an 
irregular, polygonal shape with rough borders. In the following days (96 hours) cells 
turned to a more elongated shape and proliferated. Cells compacted in discrete foci, 
each leading to dome-like outgrowths from which a floating spheroid detached 
(either spontaneously or after plate tipping) that got collected as P0 cultures.  
 
Characterization of the early steps of neuronal reprograming 
 
In order to follow the early stages of YAP-induced reprogramming, YAP 
expression was induced by addition of doxycycline 24 hours before switching to 
NSC medium. By using immunofluorescence, this approach allowed following 
more closely the dynamic of individual genetically-labeled neurons expressing 
YAP. As in previous experiments, tdTomato-traced/YAP-expressing cells entered 
reprogramming as NeuN-positive and invariably Nestin-negative neurons. Just 48 
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hours after switching to NSC medium, all tdTomato-positive/YAP-expressing 
neurons lost expression of NeuN and wholesale turned on Nestin expression. 
Importantly, this transition occurred with similar efficiency even in presence of 
the anti-mitotic drug AraC (Figures 12B and C). By day 5, all the non-infected 
neurons had died and the culture consisted exclusively of YAP-expressing cells. 
Taken together, the validation of the starting cell population, the fact that yNSCs 
are genetically labeled by a bona-fide transgenic tracer specific for neurons and 
not NSCs, the rapid dynamic and essentially quantitative conversion of YAP-
expressing neurons to yNSCs, and the fact that this occurs even independently of 
proliferation, all indicate that yNSCs originate from mature neurons and argue 
against the possibility that acquisition of NSC-traits could be secondary to 
survival and expansion of rare, preexistent, contaminant endogenous NSCs. 
 
Characterization of yNSCs 
 
Next, we characterized yNSCs by marker gene expression, using 
immunofluorescence, qRT-PCR and gene expression profiling. As shown in 
Figures 13A and C, yNSCs completely lost expression of the terminal 
differentiation markers present in the original neurons (such as TuJ1, Tau and 
NeuN), and instead expressed high levels of NSC markers (Nestin, Sox2, 
Vimentin), and to levels comparable to native NSCs. Note also that in 2D cultures 
yNSCs and native NSCs are morphologically indistinguishable (Figure 13A). 
In order to characterize to what extent YAP triggers conversion of neurons into a 
bona-fide NSC-status, we compared the transcriptome of parental neurons, yNSCs 
and native NSCs. As shown in Figure 13B, yNSCs completely lost their neuronal 
identity and acquired a gene expression profile closely similar to native NSCs. By 
Gene Ontology (GO), genes upregulated in both yNSCs and NSCs were 
specifically enriched of gene categories associated to positive regulation of the 
cell cycle and development/maintenance of the neural progenitor state. Genes 
downregulated in both yNSCs and NSCs were specifically enriched for GO terms 
related to terminal differentiation of neurons, transmission of nerve impulse, and 
nerve cell function. 	
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yNSCs display tripotent differentiation potential 
 
Neural SCs are defined as tripotent, as attested by their ability to differentiate in 
astrocytes, neurons and oligodendrocytes. We thus examined the differentiation 
potential of yNSCs. Once plated on fibronectin and treated with BMP4 and LIF 
(Bonaguidi et al., 2005), yNSCs completely switched to typical astrocyte 
morphology, expressing high levels of GFAP (Figure 14A, left panels). For 
neuronal differentiation, we implemented a recently reported culture system 
involving plating of NSCs on Matrigel (Choi et al., 2014) (see Experimental 
procedures). In these conditions, yNSCs underwent widespread differentiation in 
neurons, characterized by an extensive neurite outgrowth, that were TuJ1- and 
Tau-positive but Nestin-negative  (Figure 14A, middle panels and Figure 14B). 
Moreover, upon treatment with IGF and T3 (Hsieh et al., 2004), yNSCs could also 
differentiate into oligodendrocytes, displaying the typical branching morphology 
and CNPase positivity (Figure 14A, right panels).  
To investigate the in vivo differentiation potential of yNSCs, we transduced yNSCs 
with lentiviral vectors encoding for constitutively expressed EGFP and transplanted 
EGFP-labeled yNSCs in the brain of newborn mice (n=5). Four weeks after 
transplantation, grafted yNSCs invariably lost Nestin positivity (Figure 14C) and 
mainly remained close to the injection site, where they primarily acquired expression 
of GFAP, indicative of astrocyte-differentiation (Figures 14D,E). However, some 
cells migrated away from the graft (Figure 14F) and differentiated in NeuN- and 
TuJ1-positive neurons or CNPase-positive oligodendrocytes (Figure 14G). 
Importantly, no tumor formation was ever observed after histological examination of 
the yNSCs-injected brain parenchyma. Thus, YAP induces conversion of neurons 
into cells that are functionally corresponding to normal NSCs. 
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DISCUSSION 
 
A dysregulated Hippo pathway has been shown to induce cell fate changes in 
transgenic livers and mammary cells (Cordenonsi et al., 2011; Fitamant et al., 2015; 
Skibinski et al., 2014; Yimlamai et al., 2014). Yet, the possibility that YAP/TAZ 
activity could be used to generate normal somatic SCs de novo remained so far 
unexplored. Here we report that expression of a single factor, YAP, into terminally 
differentiated cells explanted from different tissues efficiently creates cells with 
functional and molecular attributes of their corresponding tissue-specific SCs, that 
can be expanded ex-vivo as organoid cultures. The ySC state can be transmitted 
through cell generations without need of continuous expression of ectopic 
YAP/TAZ, indicating that a transient activation of YAP or TAZ is sufficient to 
induce a heritable self-renewing state.  
 
YAP turns terminally differentiated cells into SC-like cells. 	
We used several approaches to validate the notion that ySCs originate from 
conversion of fully differentiated cells, rather than from amplification of 
contaminant, rare, pre-existing, tissue SCs. This notion is supported primarily by 
tracing of differentiated cells with established lineage-specific Cre-drivers. 
Pancreatic acinar cells were labeled with Ptf1a-CreERTM: upon tamoxifen treatment 
of adult mice, this driver has been previously shown to exclusively label pancreatic 
acinar cells (Pan et al., 2013), and indeed, this transgenic line has been previously 
employed to demonstrate that KRas-induced tumors in fact originated from acinar 
cells (Kopp et al., 2012). As for neurons, we adopted a well-established neuronal 
specific driver, Syn1-Cre that has been used, as confirmed here, to mark post-mitotic 
neurons already in embryos (Zhu et al., 2001). Endogenous pancreatic progenitors or 
NSCs derived from the same mice employed to derive differentiated exocrine acini 
or neurons, respectively, were never labeled, collectively supporting the view that 
differentiated cells are the cellular targets of YAP. Most importantly, in no case we 
could detect dedifferentiation or emergence of spheroids in control cultures infected 
with the sole rtTA, empty vectors or a point-mutant of YAP unable to interact with 
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TEAD, the YAP/TAZ DNA binding platform. Collectively, these data do not favor 
the notion that rare stem cells may be the origin of YAP-induced SCs.  
YAP-induced reprograming generates cells with normal SC traits, as: i) ySCs are non 
transformed and non tumorigenic; ii) ySCs are endowed with differentiation potential 
and can generate a multilineage progeny, in a manner indistinguishable from their 
corresponding native SCs; iii) at the transcriptomic level, ySCs display massive 
overlaps with native SCs; iv) in the case of yNSCs, we could also show as proof-of-
principle that these cells display multilineage differentiation capacity also when 
transplanted in vivo. 
 
YAP/TAZ as the centerpiece of somatic cell plasticity 	
Lineage infidelity and reversion to a SC-like status rarely occur during homeostasis 
of normal tissues, but are associated to tissue repair or oncogenic activation 
(Blanpain and Fuchs, 2014; Lim et al., 2009; Robel et al., 2011; Skibinski et al., 
2014; Tetteh et al., 2015; Yimlamai et al., 2014). Of note, genetic depletion of YAP 
and/or TAZ in several adult epithelia is inconsequential for normal homeostasis, but 
in fact absolutely essential for regeneration, tumor growth (Azzolin et al., 2014; 
Bailleul et al., 1990; Cai et al., 2010; Mani et al., 2008), and, as shown here, for 
expansion of somatic SCs in vitro. It is thus tempting to propose YAP/TAZ as 
"master-genes" required and sufficient for somatic cell plasticity and SC maintenance 
whenever natural, pathological or ex-vivo conditions demand de novo generation and 
expansion of resident or facultative SCs.  
It is intriguing to note that previous work on YAP/TAZ and its ability to convert non-
stem tumor cells into cancer-SCs (Cordenonsi et al., 2011) may be re-interpreted as a 
role of YAP/TAZ in controlling cell plasticity even within established tumors. 
Further work is required to dissect the means by which expression of YAP 
overcomes the differentiated cell state and triggers a stable, de novo SC status in 
distinct cell types. At the molecular level, this is clearly linked to YAP-regulated 
gene transcription, relying on YAP binding to its transcriptional partner TEAD, as 
we show that ySC generation is impaired after YAP is mutated at a residue critical 
for the association to TEAD (YAP S94A). Gene-expression studies provided some 
intriguing mechanistic insights, as we found that YAP induces several genes known 
to be instrumental for SC self-renewal and/or functionally implicated in SC biology 
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for the various tissues here analyzed. This includes transcription factors, such as 
Sox2 and Sox9 that are essential for maintenance/regeneration of NSCs and 
pancreatic progenitors, respectively (Favaro et al., 2009; Seymour et al., 2007). Of 
note, it has been recently shown that, in the embryonic pancreas, Sox9 is directly 
induced by YAP through a TEAD-bound enhancer (Cebola et al., 2015), at least 
suggesting that some of the factors involved in somatic SC biology may be direct 
YAP/TAZ targets. Moreover, although the activation of cell proliferation is clearly a 
hallmark of ySC generation, our work at least suggests that the early stages of 
reprogramming are independent of induction of cell proliferation.  
We further note that YAP/TAZ are not just “exogenous” triggers of a de novo SC 
state but also the endogenous factors enriched in the corresponding native SCs, 
required to maintain their organoid-forming potential ex-vivo, as validated for all the 
cell types here investigated. These results at least suggest the existence of a 
YAP/TAZ-centered stemness network in various types of somatic SCs, whose 
components remain to be identified. We can only speculate at this stage that 
YAP/TAZ must intersect with lineage- and cell-specific transcription factors, 
possibly at composite enhancer elements (Zanconato et al., 2015), to turn off 
transcription of terminally differentiated traits and concomitantly sustain expression 
of progenitor-specific genes while respecting tissue-barriers. 
 
ySCs represent a novel reprograming paradigm  
 
Immortalized or transformed cell lines are the workhorses of cell biology; however, 
it is still unclear to what extent the biology of normal cells may be recapitulated by 
these models. Moreover, for each histotype, the number of available cell lines is 
restricted, and each line diverges from the others and their tissue of origin for a 
number of genetic and epigenetic abnormalities. This complicates interpretation and 
modeling of diseases, as each patient carries a specific subset of genetic alterations 
and a unique genetic milieu. Thus, a potential application of the reprograming 
procedure here presented is the possibility to generate, expand and functionally 
interrogate in vitro patient-specific cells of various tissue sources starting from 
abundant differentiated cells, even in conditions in which resident SCs are not 
available because naturally rare, old, not extractable from a living body or exhausted 
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by damage or disease. Differently from iPSCs, the reprogramming to ySCs preserves 
the epigenetic memories of the tissue of origin, eliminating the need to differentiate 
pluripotent cells along with the risks associated to their intrinsic tumorigenicity (Ben-
David and Benvenisty, 2011).  
Another paradigm for changing cell fate and for in vitro generation of patient-
specific cell types is directed differentiation, aiming to convert one somatic cell into 
another mature cell type. Reprogramming to ySCs may overcome the fundamental 
limitation of this approach, as mature cells are typically postmitotic or lack 
significant proliferative potential; this limits the number of cells that can be 
generated and thus compromises long-term expandability, self-organization and 
organ repopulation potentials, all features that appear essential for most present and 
future applications. YAP-induced SCs may thus expand the current reprogramming 
paradigms by focusing on somatic stem cell generation, a state that has been so far 
challenging to capture.  
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EXPERIMENTAL PROCEDURES 
 
 Reagents, plasmids and transfections 
 
Doxycycline hyclate, fibronectin, collagen I, insulin, dexamethasone, SBTI (Soybean 
Trypsin Inhibitor), gastrin, N-acethylcysteine, nicotinamide, T3 (Triiodo-L-
Thyronine), tamoxifen and 4-OH-tamoxifen were from Sigma. Murine EGF, murine 
bFGF, human FGF10, human Noggin, human IGF, murine BMP4 were from 
Peprotech. N2, B27, BPE and ITS-X (Insulin-Transferrin-Selenium-Ethanolamine) 
supplements were from Life Technologies. R-Spondin1 was from Sino Biological. 
Matrigel was from BD Biosciences (Corning). Rat tail collagen type I was from 
Cultrex. 
GFP- and Cre-expressing adenoviruses were from University of Iowa, Gene Transfer 
Vector Core. For inducible expression of YAP and TAZ, cDNA for siRNA-insensitive 
Flag-hYAP1 wt, S94A (TEAD-binding mutant; (Zhao et al., 2008)) were subcloned in 
FUW-tetO-MCS, obtained by substituting the Oct4 sequence in FUW-tetO-hOct4 
(Addgene #20726; (Hockemeyer et al., 2008)) with a new multiple cloning site (MCS). 
This generated the FUW-tetO-wtYAP, FUW-tetO-YAPS94A used throughout this 
study. FUW-tetO-MCS (empty vector) or FUW-tetO-EGFP plasmids were used as 
controls, as previously indicated (Cordenonsi et al., 2011).  
For stable expression of GFP, pRRLSIN.cPPT.PGK-GFP.WPRE (gift of L. Naldini) 
lentiviral vector was used. All constructs were confirmed by sequencing.  
DNA transfections were done with TransitLT1 (Mirus Bio) according to manufacturer 
instructions. 
 
Lentivirus preparation 
 
HEK293T cells (checked routinely for absence of mycoplasma contaminations) were 
kept in DMEM supplemented with 10% FBS (Life Technologies), Glutamine and 
Antibiotics (HEK medium). Lentiviral particles were prepared by transiently 
transfecting HEK293T with lentiviral vectors (10 micrograms/10 cm dishes) together 
with packaging vectors pMD2-VSVG (2.5 micrograms) and pPAX2 (7.5 micrograms) 
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by using TransIT-LT1 (Mirus Bio) according to manufacturer instructions. 
Specifically, 60 µl of TransIT-LT1 reagent was diluted in 1.5 ml of Opti-MEM (Life 
Technologies) for each 10 cm dish, incubated with the vector DNA 15 min at RT and 
gently distributed over to the cell medium (dish contained about 10 ml of HEK 
medium). After 8 hr, HEK medium was changed. 48 hr post-transfection supernatant 
was collected, filtered through 0.45 micrometers and directly stored at -20°C; we did 
not concentrate viral supernatants. For a typical infection of a 3 cm dish containing 
primary cells, we used 500 µl of each unconcentrated viral supernatant diluted to 1x 
cell-specific medium (see below) in 2 ml final volume. We also seldom measured the 
lentiviral titer of various supernatants used in our experiments using the QuickTiter 
Lentivirus Titer kit (lentivirus-associated HIV p24; Cell Biolabs) according to the 
manufacturer’s protocol. As reference, viral supernatants were in the range 16 - 20 ng 
of p24/ml. This titer corresponds to a viral particle concentration of about 2x108 
particles/ml. As determined by PCR of integrated lentiviral DNA of HEK293T 
transduced with pRRL-EGFP, this roughly corresponds to 2x106 transduction units 
(TU)/ml in the unconcentrated viral supernatant stock.  
 
Pancreatic acinar cells isolation and induction of yDucts  
 
Primary pancreatic acini were isolated from the pancreas of 6- to 9-week-old mice, 
according to standard procedures (Means et al., 2005). Digested tissue was filtered 
through a 100 µm nylon cell strainer. The quality of isolated acinar tissue was checked 
under the microscope. For culture of entire acini, explants were seeded in neutralized 
rat tail collagen type I (Cultrex)/acinar culture medium (1:1) (Means et al., 2005), 
overlaid with acinar culture medium (Waymouth’s medium (Life Technologies) 
supplemented with 0.1% FBS (Life Technologies), 0.1% BSA, 0.2 mg/ml SBTI, 1x 
ITS-X (Life Technologies), 50 µg/ml BPE (Life Technologies), 1µg/ml 
dexamethasone (Sigma), and antibiotics) once collagen formed a gel. For induction of 
pancreatic organoids, entire acini of the indicated genotypes were seeded in medium 
supplemented with 2 µg/ml doxycycline. Negative control cells were cultured in the 
same conditions in absence of doxycycline. Cells were treated with 2 µg/ml 
doxycycline for 7 days and organoid formation was morphologically followed. 
Organoids were then passaged or processed for further analyses. To assess enrichment 
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of acinar cells in our preparation, we compared RNA extracts from whole pancreas 
and our fresh acinar cell preparation for expression of exocrine cell markers, such as 
α-amylase, elastase and CPA1, normalized to 18-S rRNA and found a >400 fold 
enrichment of these markers in acinar preparations. 
For the experiment depicted in Figures 8B-D (see also scheme in Figure 8A), we 
obtained acinar explants from 6 week-old Ptf1a-CreERTM; R26-LSL-rtTA-IRES-
EGFP/+; tetO-YAPS127A mice (Pan et al., 2013). Mice with this genotype were given 
tamoxifen by three daily i.p. injections of a 10 mg/ml solution in corn oil. 1 week after 
the last tamoxifen injection, mice were sacrificed and pancreas was dissociated to 
obtain rtTA-IRES-EGFP+-labeled exocrine acinar cells. Primary pancreatic acinar cells 
were isolated and cultured as above. For induction of pancreatic organoids, acinar 
explants were treated with 2 µg/ml doxycycline as above. 
 
Matrigel culture of yDucts organoids 
 
To show the self-renewal capacity of pancreatic organoids independently of 
exogenous YAP supply (i.e, independently of doxycycline administration), organoids 
were recovered from collagen cultures, trypsinized to obtain a single cell suspension 
and re-seeded in 100% Matrigel. Once Matrigel formed a gel, cells were supplemented 
with pancreatic organoid medium (Advanced DMEM/F12 supplemented with 1x B27, 
1.25mM N-Acetylcysteine, 10 nM gastrin, 50 ng/ml murine EGF, 100 ng/ml human 
Noggin, 100 ng/ml human FGF10, 10 mM Nicotinamide, 1 µg/ml R-Spondin1 and 
antibiotics) supplemented with 0.2 mg/ml SBTI. For analysis, organoids were 
recovered from Matrigel and processed for immunofluorescence or for protein or RNA 
extraction.  
For the differentiation experiments shown in Figure 9D, yDucts were removed from 
Matrigel, trypsin-dissociated and seeded as single cells in Matrigel- coated (1:50) 
chamber slides. Cells were expanded in DMEM supplemented with 0.5% BSA, 1% 
ITS-X and 1x N2 and 50 ng/ml EGF and antibiotics for 5 days. For differentiation, 
cells were switched to DMEM/F12 supplemented with 1% ITS-X, 10 ng/ml bFGF, 10 
mM nicotinamide, 50 ng/ml Exendin-4 and 10 ng/ml BMP4 and antibiotics for further 
8 days. Cells were fixed in 4% PFA at Day 0 or Day 8 of differentiation and processed 
for immunofluorescence.      
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Culture of pancreatic ductal organoids (Ducts) 
 
For culture of pancreatic duct-derived organoids, pancreatic ducts were isolated from 
the bulk of the pancreas as	 previously described (Huch et al., 2013) with minor 
modifications. The whole pancreas of 6- to 9-week-old mice of the indicated 
genotypes was grossly minced and digested by collagenase/dispase dissociation: 
DMEM medium (Life Technologies) supplemented with collagenase type XI 0.012% 
(w/v) (Sigma), dispase 0.012% (w/v) (Life Technologies), 1% FBS (Life 
Technologies) and antibiotics at 37°C for 1 hour. Isolated pancreatic duct fragments 
were hand-picked under a dissecting microscope, carefully washed in DMEM medium 
and embedded in 100% Matrigel. After Matrigel formed a gel, pancreatic organoid 
medium (Advanced DMEM/F12 supplemented with 1x B27, 1.25mM N-
Acetylcysteine, 10 nM gastrin, 50 ng/ml murine EGF, 100 ng/ml human Noggin, 100 
ng/ml human FGF10, 10 mM Nicotinamide, 1 µg/ml R-Spondin1 and antibiotics) was 
added. Ductal fragments rapidly expanded to form cyst-like organoids within 5 days. 
Organoids were removed from Matrigel by incubation in ice cold HBSS, dissociated 
with trypsin 0.05% for 30 min to obtain a single cells suspension and reseeded in 
100% fresh Matrigel. Organoid cultures were maintained for at least 9 months 
passaging every 10 days. For analysis, organoids were recovered from Matrigel as 
above and processed for immunofluorescence or for protein or RNA extraction.  
For the experiments depicted in Figure 5D, pancreatic duct fragments were isolated 
from 9 weeks old Yapfl/fl; Tazfl/fl mice, embedded in 100% Matrigel and cultured as 
above. Organoids were passaged once every 10 days. After at least 3 months of culture, 
organoids were removed from Matrigel by incubation in ice cold HBSS, trypsin-
dissociated and transduced with adenovirus encoding for CRE recombinase to induce 
Yap/Taz knockout (or with GFP-encoding adenovirus as control). Single cells were 
resuspended in 2 ml Advanced DMEM/F12, transduced for 2 hours at 37°C with 
adenovirus, washed in Advanced DMEM/F12 and seeded in 100% Matrigel. After 
Matrigel formed a gel, cells were maintained in pancreatic organoid medium and 
organoid formation capacity was morphologically monitored over a period of 10 days. 
Pancreatic ductal organoids obtained from wt mice were used as additional controls 
and treated as above.  
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Single-cell gene expression analysis during the conversion of pancreatic acinar 
cells to yDucts 
 
For the experiment depicted in Figure 8F, we dissociated and harvested single cells 
from pancreatic cultures of the R26-rtTA; tetO-YAP S127A genotype during the YAP-
induced conversion from acinar cells to yDucts, that is at: day 0 = starting acini 
(without doxycycline); day 2 = cultures that have experienced 48 hours of 
doxycycline; day 4 = cultures that have experienced 96 hours of doxycycline; yDucts 
= yDucts obtained as above (n= 12/13 each time point). Single cells were collected by 
pipetting into 200 µl- conical tubes and processed for total RNA extraction, retro-
transcription and pre-amplification with Single Cell-to-CT kit (Ambion), according to 
manufacturer’s protocol. Specific target amplification products were then processed 
for qRT-PCR analysis on QuantStudio 6 Flex Real-time PCR System, 384-well 
(Applied Biosystems) with the following Taqman Gene Expression Assays: 18S 
(Hs99999901_s1), Amy2a5  (Mm02342486_mH), Ptf1a (Mm00479622_m1), Nestin 
(Mm00450205_m1), Krt19 (Mm00492980_m1), Sox9 (Mm00448840_m1), Car2 
(Mm00501576_m1), Pdx1 (Mm00435565_m1), Ctgf (Mm01192933_g1), Myc 
(Mm00487804_m1), Ccnd1 (Mm00432359_m1). Expression levels were normalized 
to 18S-rRNA for each sample. 
 
Primary neuron isolation and induction of yNSCs 
 
Neurons were prepared from hippocampi or cortices of E18-19 embryos or newborn 
mice as previously described (Han et al., 2008). Briefly, hippocampi and cortices were 
dissected under the microscope in ice cold HBSS as quickly as possible, incubated 
with 0.05% trypsin (Life Technologies) 15 min at 37°C and, after trypsin blocking, 
resuspended in DMEM/10% FBS supplemented with 0.1 mg/ml DNase I (Roche), and 
mechanically dissociated by extensive pipetting. Cells were then plated on poly-L-
lysine-coated wells in DMEM supplemented with 10% FBS, glutamine and antibiotics 
for hippocampal neurons, or in DMEM/Neurobasal (1:1) supplemented with 5% FBS, 
1x B27, glutamine and antibiotics for cortical neurons (day 1). After 24 hours (day 2), 
the medium of both hippocampal and cortical preparation was changed to fresh 
DMEM/Neurobasal (1:1) supplemented with 5% FBS, 1X B27, glutamine and 
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antibiotics. For reprogramming experiments neurons were infected on the following 
day (day 3) with FUW-tetO-wtYAP and FUdeltaGW-rtTA viral supernatants. 
Negative controls were provided by neurons transduced with FUdeltaGW-rtTA alone 
or in combination with FUW-tetO-EGFP or FUW-tetO-MCS (empty vector).  For this, 
for a typical 3.5 cm plate, we mixed 500 µl of FUdeltaGW-rtTA with 250 µl of FUW-
tetO-wtYAP (or negative controls) viral supernatants, 250 µl of HEK medium with 1.5 
ml of serum-free Neurobasal medium with 2X B27. After 24 hour (day 4), medium 
was changed and cells were incubated in Neurobasal medium supplemented with 1X 
B27, glutamine, antibiotics, and 5 µM Ara-C (cytosine β-D-arabinofuranoside; Sigma) 
for additional 7 days, at the end of which well-differentiated, complex network-
forming neurons are visible. To induce yNSCs formation, treated neurons were 
switched to NSC medium (DMEM/F12 supplemented with 1X N2, 20 ng/ml murine 
EGF, 20 ng/ml murine bFGF, glutamine, and antibiotics) and 2 µg/ml doxycycline for 
activating tetracycline-inducible gene expression. After 7 days, fresh doxycycline 
(final concentration of 2 µg/ml) was added. Sphere formation was evident upon YAP 
induction after 14 days of doxycycline treatment (see scheme in Figure 10B). These 
“P0” spheres were gently transferred into a 15 ml-plastic tube and let sediment 
(typically 10-15 min). After discarding the supernatant, spheres were dissociated with 
TrypLE Express (Life Technologies) at room temperature for 5 min and mechanical 
pipetting. TrypLE Express was diluted in NSC medium (in case of clumps of genomic 
DNA, we recommend to degrade it with DNase I at this stage) and cells were 
resuspended in NSC medium without doxycycline. For the successive passages, 
spheres were harvested and dissociated and yNSCs were routinely cultured and 
passaged without doxycycline in NSC medium, as for normal NSCs.  
 
For the experiment depicted in Figures 11B-D and Figure 12, we obtained cortical 
neurons from Syn1-Cre; R26-CAG-LSL-tdTomato/+ embryos (day 1 and 2 as above). 
When indicated, these cells were transduced as above (day 3). Cells were then treated 
with AraC/B27 containing medium as before and, after 7 days, switched to 
doxycycline containing-NSC medium to activate YAP expression and induce yNSC 
formation from tdTomato-positive neurons. Syn1-Cre; R26-CAG-LSL-tdTomato/+ 
neurons transduced with FUdeltaGW-rtTA in combination with FUW-tetO-EGFP or 
FUW-tetO-YAPS94A never gave rise to any neurospheres. Each embryo genotype 
	 49	
was confirmed on tail biopsies post-brain dissociation; as separate negative controls, 
neurons derived from R26-CAG-LSL-tdTomato/+ littermates (Syn1-Cre negative) 
were transduced with FUW-tetO-wtYAP and FUdeltaGW-rtTA viral supernatants as 
above, and never gave rise to tdTomato-positive yNSCs. These same neurons 
transduced with FUdeltaGW-rtTA in combination with FUW-tetO-EGFP or FUW-
tetO-YAPS94A never gave rise to any neurospheres.  
To validate the specificity of the neuronal driver, primary NSCs were derived as 
below from Syn1-Cre; R26-CAG-LSL-tdTomato/+ embryos and we verified the 
negativity for tdTomato (see Figure 12A). 
 
Primary neural stem cells (NSCs) isolation and culture 
 
Neural stem cells (NSCs) were isolated as previously reported (Ray and Gage, 2006) 
from the telencephalon of C57BL/6J E18 embryos or from mice of the indicated 
genotype. Telencephalons were minced and digested in trypsin 0.05% for 10 min at 
37°C. The cell suspension was treated with DNaseI (Roche) and washed. NSCs were 
cultured in DMEM/F12 supplemented with N2, 20 ng/ml murine EGF, 20 ng/ml 
murine bFGF, glutamine and antibiotics. For passages, neurospheres were dissociated 
into single cells with TrypLE Express (Life Technologies).  
 
NSCs/yNSCs infection and differentiation 
 
For adenoviral infection of wild-type (wt) or double Yapfl/fl; Tazfl/fl NSCs (Figure 6C), 
single cells were plated in NSC medium containing adeno-Cre on ultra-low attachment 
plates and allowed to form neurospheres for 7 days. 
For neuronal differentiation, NSCs or yNSCs were cultured over a thin Matrigel layer. 
Differentiation medium was Neurobasal supplemented with 1x B27, glutamine. 
For astrocyte differentiation, NSCs or yNSCs were plated on fibronectin coated-plate 
in NSC medium, to allow a 2D culture. The next day, medium was changed to DMEM 
(Life Technologies) containing 25 ng/ml LIF, 25 ng/ml BMP4, glutamine, and 
antibiotics for 2 weeks. 
For oligodendrocyte differentiation, NSCs or yNSCs were plated on fibronectin 
coated-plate in NSC medium, to allow a 2D culture. The next day, medium was 
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changed to Neurobasal (Life Technologies) containing 1x B27, 500 ng/ml IGF, 30 
ng/ml T3, glutamine, and antibiotics for 2 weeks. 
 
NSCs transplantation 
 
P0 CD1 mice pups were used for cell transplantations. Pups were anesthetized by 
hypothermia (3 minutes) and fixed on ice-cold block during cell injection. Cells were 
resuspended in ice-cold HBSS (5x104 cells/µl) and injected into both hemispheres of 
neonatal mice with a 5µl-volume Hamilton syringe (2µl/injection). One month after 
the procedures, the grafted animals were perfused with PBS and 4%PFA, and the 
brains were excised and processed for immunofluorescence.  
 
Immunofluorescence, stainings and microscopy 
 
Immunofluorescences on PFA-fixed samples were performed as previously described 
(Cordenonsi et al., 2011). Briefly, samples were ﬁxed 10 min at room temperature 
with 4% PFA solution. Slides were permeabilized 10 min at RT with PBS 0.3% Triton 
X-100, and processed for immunoﬂuorescence using the following conditions: 
blocking in 10% Goat Serum (GS) in PBS 0.1% Triton X-100 (PBST) for 1 hr 
followed by incubation with primary antibodies (diluted in 2% GS in PBST) overnight 
at 4°C, four washes in PBST and incubation with secondary antibodies (1:200 in 2% 
GS in PBST) for 2 hours at room temperature. Samples were counterstained with 
ProLong-DAPI (Molecular Probes, Life Technologies) to label cell nuclei. 
For immunofluorescence on pancreatic organoids or acini (Figure 5B and Figure 9B), 
pancreatic acini and organoids were fixed overnight in PBS 4% PFA at 4°C, 
permeabilized with two washes in PBS 0.5% NP40 for 20 minutes at 4°C, followed by 
one wash in PBS 0.3% Triton X-100 for 20 minutes at room temperature. After two 
washes in PBS 0.1% Triton X-100 (PBST) for 15 minutes at room temperature, acini 
or organoids were blocked with two washes in PBST 10% GS for 1 hour at room 
temperature, and incubated overnight with primary antibodies. The following day, 
cells were washed twice in PBST 2% GS for 15 minutes at 4°C, and five more times 
in PBT 2% GS for 1 hour at 4°C. Secondary antibodies were incubated overnight. The 
third day, cells were washed five times in PBST for 15 minutes, incubated 20 min with 
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DAPI solution and mounted in glycerol. 
For immunofluorescence on brain tissue, biopsies were fixed with PFA, paraffin-
embedded and cut in 10 µm-thick sections. Sections were re-hydrated and antigen 
retrieval was performed by incubation in citrate buffer 0.01 M pH 6 at 95°C for 20 
minutes. Slides were then permeabilized (10 min at RT with PBS 0.3% Triton X-100 
for mammary sections and 10 min at RT with PBS 1% Triton X-100 for brain 
sections) and processed as described above.  
Primary antibodies: anti-YAP (4912; 1:25) polyclonal antibody, anti-CNPase (5664S; 
1:100) polyclonal antibody, anti-SOX2 (4900; 1:50) monoclonal antibody were from 
Cell Signaling Technology. anti-TAZ (anti-WWTR1, HPA007415; 1:25) polyclonal 
antibody, and anti-amylase (A8273: 1:200) rabbit polyclonal antibody was from 
Sigma. anti-TuJ1 (anti β-III-tubulin; MMS435P-100; 1:500) mouse monoclonal 
antibody was from Covance. Anti-Synaptophysin (M0776; 1:200) mouse monoclonal 
antibody and anti-GFAP (Z0334; 1:1000) rabbit polyclonal antibody was from Dako. 
anti-Nestin (MAB353; 1:300) mouse monoclonal antibody and anti-Sox9 (AB5535; 
1:200) and anti-NeuN (ABN78; 1:1000) rabbit polyclonal antibodies were from 
Millipore. Anti-Mash1 (556604; 1:100) monoclonal antibody was from BD 
Biosciences. Anti-NeuN (Ab177487; 1:100) rabbit monoclonal antibody and anti-GFP 
(Ab13970; 1:100) polyclonal antibody were from Abcam. anti-GFP (A6455; 1:100) 
rabbit serum was from Life Technologies. Anti-YAP (63.7; sc-101199; 1:200) mouse 
monoclonal antibody, anti-SV2a (E-8; sc-376234; 1:200) mouse monoclonal antibody 
and anti-Vimentin (Vim C-20, sc-7557-R; 1:100) rabbit polyclonal antibody were 
from Santa Cruz. anti-Tau (1:100) rabbit polyclonal antibody was from Axell. Anti-
Ki67 (M3060; 1:100) rabbit monoclonal antibody was from Spring Bioscience. K19 
was detected using the monoclonal rat anti-Troma-III antibody (DSHB; 1:50). Alexa-
conjugated secondary antibodies (Life Technologies): Alexa-Fluor-488 donkey anti-
mouse IgG (A21202); Alexa Fluor-568 goat anti-mouse IgG (A11031); Alexa-Fluor-
647 donkey anti-mouse (A31571); Alexa Fluor-488 goat anti-mouse IgG2a (A21131), 
Alexa Fluor-647 goat anti-mouse IgG1 (A21240), Alexa Fluor-488 donkey anti-rabbit 
IgG (A21206), Alexa-Fluor-568 goat anti-rabbit IgG (A11036), Alexa-Fluor-647 
donkey anti-rabbit IgG (A31573); Alexa Fluor-555 goat anti-chicken IgG (A21437). 
Goat anti-rat Cy3 (112-165-167) was from Jackson Immunoresearch. 
Confocal images were obtained with a Leica TCS SP5 equipped with a CCD camera. 
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Bright field and native-tdTomato images were obtained with a Leica DM IRB inverted 
microscope equipped with a CCD camera (Leica DFC 450C).  
 
Western blot 
 
Western blots were carried out as described in Cordenonsi et al., 2011. Anti-
YAP/TAZ (63.7; sc-101199) was from Santa Cruz. anti-GAPDH (MAB347) 
monoclonal antibody was from Millipore. Anti-E-cadherin (610181) was from BD 
Transduction Laboratories 
 
Quantitative Real-Time PCR (qRT-PCR)   
 
Cells or tissues were harvested in TriPure (Roche) for total RNA extraction, and 
contaminant DNA was removed by DNase treatment. qRT-PCR analyses were carried 
out on retrotranscribed cDNAs with Rotor-Gene Q (Qiagen) thermal cycler and 
analyzed with Rotor-Gene Analysis6.1 software. Expression levels are always given 
relative to Gapdh, except for Figure 5C and 9A in which expression levels were 
normalized to 18-S rRNA. PCR oligo sequences for mouse samples are listed in Table 
2. 
 
Microarray experiments and RNA sequencing 
 
For microarray experiments, Mouse Genome 430 2.0 arrays (Affymetrix, Santa Clara, 
CA, USA) were used. Total RNA was extracted using TriPure (Roche) from: 
1) pancreatic exocrine acini (4 replicates), yDucts (passage 10; 4 replicates), and Ducts 
(passage 10; 4 replicates). 
2) cortical neurons (3 replicates), yNSCs (from YAP wild type-transduced cortical 
neurons, passage 2; 3 replicates), and native NSCs (3 replicates); 
RNA quality and purity were assessed on the Agilent Bioanalyzer 2100 (Agilent 
Technologies, Waldbronn, Germany); RNA concentration was determined using the 
NanoDrop ND-1000 Spectrophotometer (NanoDrop Technologies Inc.). RNA was 
then treated with DNaseI (Ambion). In vitro transcription, hybridization and biotin 
labeling were performed according to Affymetrix 3’IVT protocol (Affymetrix). As 
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control of effective gene modulation and of the whole procedure, we monitored the 
expression levels of tissue-specific markers of differentiated cells or stem/progenitors 
by qRT-PCR prior to microarray hybridization and in the final microarray data. 
All data analyses were performed in R (version 3.1.2) using Bioconductor libraries 
(BioC 3.0) and R statistical packages. Probe level signals were converted to log2 
expression values using robust multi-array average procedure RMA (Irizarry et al., 
2003) of Bioconductor affy package. Raw data are available at Gene Expression 
Omnibus under accession number GSE70174. 
Global unsupervised clustering was performed using the function hclust of R stats 
package with Pearson correlation as distance metric and average agglomeration 
method. Gene expression heatmaps have been generated using the function heatmap.2 
of R gplots package after row-wise standardization of the expression values. Before 
unsupervised clustering, to reduce the effect of noise from non-varying genes, we 
removed those probe sets with a coefficient of variation smaller than the 90th 
percentile of the coefficients of variation in the entire dataset. The filter retained 4511 
probe sets that are more variable across samples in any of the 2 subsets (i.e., neuron 
and pancreatic). 
Differentially expressed genes were identified using Significance Analysis of 
Microarray algorithm coded in the samr R package as in (Tusher et al., 2001). To 
identify differentially expressed genes, we selected those probe sets with an FDR ≤ 
1%.  
Genes that were coherently up- or downregulated in yNSC and in NSC in comparison 
to neurons were functionally annotated to Gene Ontology categories using the DAVID 
Bioinformatic resources. GO terms were selected with a Benjamini FDR ≤ 5%. 
Upregulated genes are enriched of GO terms related to positive regulation of cell cycle 
(e.g. GO:0007049~cell cycle, GO:0007067~mitosis, GO:0006260~DNA replication) 
and to the development of the nervous system and maintenance of the neural 
progenitor state (e.g.: GO:0051960~regulation of nervous system development, 
GO:0045165~cell fate commitment, GO:0045665~negative regulation of neuron 
differentiation). Downregulated genes are enriched of GO terms related to terminal 
differentiation of neurons (e.g.: GO:0030182~neuron differentiation, 
GO:0031175~neuron projection development, GO:0007409~axonogenesis), 
transmission of nerve impulse (e.g.: GO:0007268~synaptic transmission, 
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GO:0019226~transmission of nerve impulse, GO:0006811~ion transport, 
GO:0046903~secretion) and nerve cell function (e.g.: GO:0007610~behavior, 
GO:0007611~learning or memory).  
GO terms associated to genes coherently upregulated in Ducts and yDucts in 
comparison with acinar cells included RNA processing, positive regulation of cell 
cycle and control of cell death. 
 
Mice  
 
C57BL/6J mice and NOD-SCID mice were purchased from Charles River. Transgenic 
lines used in the experiments were gently provided by: Duojia Pan (Zhang et al., 2010) 
(Yap1fl/fl); Ivan De Curtis and Riccardo Brambilla (Syn1-Cre) (Zhu et al., 2001); 
Giorgio Carmignoto (R26-CAG-LSL-tdTomato) (Madisen et al., 2010); Fernando 
Camargo	 (tetO-YAPS127A) (Camargo et al., 2007).  Tazfl/fl and double Yapfl/fl; Tazfl/fl 
conditional knock-out mice were as described in (Azzolin et al., 2014). Ptf1a-
CreERTM (stock #019378), and R26-rtTAM2 mice (stock #006965) were purchased 
from The Jackson Laboratory. Animals were genotyped with standard procedures 
(Morsut et al., 2010) and with the recommended set of primers. Animal experiments 
were performed adhering to our institutional guidelines as approved by OPBA. 
To obtain Syn1-Cre lineage tracing studies, we used Syn1-Cre hemizygous females (as 
transgene expression in male mice results in germline recombination; Rempe et al., 
2006) with R26-CAG-LSL-tdTomato homozygous males. Littermate embryos derived 
from these crossings were harvested at E18-19 and kept separate for neurons 
derivation; genotypes were confirmed on embryonic tail biopsies.  
To obtain R26-rtTAM2/+ ; tetO-YAPS127A mice, we crossed R26-rtTAM2/+ mice with 
tetO-YAPS127A mice. R26-rtTAM2/+ littermates were used as negative control.  
To obtain Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/+; tetO-YAPS127A mice, we 
crossed Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/LSL-rtTA-IRES-EGFP mice 
with tetO-YAPS127A mice. Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP/+ littermates 
were used as negative control.   
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Statistics 
 
The number of biological and technical replicates and the number of animals are 
indicated in Figure legends and text. All tested animals were included. Animal ages 
are specified in the text and Experimental procedures. Sample size was not 
predetermined. For all experiments with error bars the standard deviation (s.d.) was 
calculated to indicate the variation within each experiment. 
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Table1. Full list of neuronal markers expressed by primary neurons, 
compared to native neural stem cells (NSCs) by microarray analysis. Related 
to Figure 13B.  
 
Symbol Description 
Fold 
expression 
over NSC 
q-value 
(%) 
Calb1 calbindin 1 287,26 0 
Snap25 synaptosomal-associated protein 25 245,49 0 
Neurod6 neurogenic differentiation 6 236,53 0 
Syt4 synaptotagmin IV 229,84 0 
Tubb3 TuJ1, tubulin, beta 3 class III 205,60 0 
Gabrb2 
gamma-aminobutyric acid (GABA) A receptor, subunit 
beta 2 189,16 0 
Gabra1 
gamma-aminobutyric acid (GABA) A receptor, subunit 
alpha 1 175,44 0 
Scn2a1 sodium channel, voltage-gated, type II, alpha 1 166,39 0 
Sv2b synaptic vesicle glycoprotein 2 b 156,71 0 
Chgb chromogranin B 140,16 0 
Dlg2 discs, large homolog 2 (Drosophila) 132,72 0 
Reln reelin 110,51 0 
Caln1 calneuron 1 105,63 0 
Scg2 secretogranin II 57,92 0 
Sst somatostatin 57,54 0 
Cacnb4 calcium channel, voltage-dependent, beta 4 subunit 57,02 0 
Nrxn3 neurexin III 52,71 0 
Gria1 glutamate receptor, ionotropic, AMPA1 (alpha 1) 51,75 0 
Scn3b sodium channel, voltage-gated, type III, beta 51,10 0 
Scn3a sodium channel, voltage-gated, type III, alpha 50,63 0 
Kcnq2 potassium voltage-gated channel, subfamily Q, member 2 49,92 0 
Scn2b sodium channel, voltage-gated, type II, beta 47,45 0 
Gad1 glutamate decarboxylase 1 43,65 0 
Nsg2 neuron specific gene family member 2 43,48 0 
Clstn2 calsyntenin 2 42,07 0 
Rims1 regulating synaptic membrane exocytosis 1 42,04 0 
Mapt microtubule-associated protein tau 41,97 0 
Kcnj3 
potassium inwardly-rectifying channel, subfamily J, 
member 3 40,73 0 
Ina internexin neuronal intermediate filament protein, alpha 40,06 0 
Npy neuropeptide Y 39,21 0 
Mturn 
maturin, neural progenitor differentiation regulator 
homolog (Xenopus) 38,25 0 
Cacna2d3 
calcium channel, voltage-dependent, alpha2/delta subunit 
3 34,25 0 
Gabra4 
gamma-aminobutyric acid (GABA) A receptor, subunit 
alpha 4 33,32 0 
Caly calcyon neuron-specific vesicular protein 32,83 0 
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Symbol Description 
Fold 
expression 
over NSC 
q-value 
(%) 
Syt1 synaptotagmin I 32,59 0 
Scn1a sodium channel, voltage-gated, type I, alpha 31,56 0 
Syn3 synapsin III 31,15 0 
Rbfox3 
NeuN, RNA binding protein, fox-1 homolog (C. elegans) 
3 27,34 0 
Cend1 cell cycle exit and neuronal differentiation 1 26,58 0 
Cnr1 cannabinoid receptor 1 (brain) 26,35 0 
Nrsn1 neurensin 1 26,07 0 
Chga chromogranin A 26,07 0 
Nxph2 neurexophilin 2 23,44 0 
Kcnc2 
potassium voltage gated channel, Shaw-related subfamily, 
member 2 23,39 0 
Syp synaptophysin 23,22 0 
Syngr1 synaptogyrin 1 22,62 0 
Grin2b glutamate receptor, ionotropic, NMDA2B (epsilon 2) 21,67 0 
Syngr3 synaptogyrin 3 21,61 0 
Nefl neurofilament, light polypeptide 20,18 0 
Stx1a syntaxin 1A (brain) 20,03 0 
Cacna1b 
calcium channel, voltage-dependent, N type, alpha 1B 
subunit 19,85 0 
Penk preproenkephalin 19,78 0 
Snap91 synaptosomal-associated protein 91 19,19 0 
Neurod1 neurogenic differentiation 1 18,91 0 
Calb2 calbindin 2 16,47 0 
Camk2a calcium/calmodulin-dependent protein kinase II alpha 16,07 0 
Synpr synaptoporin 15,80 0 
Nalcn sodium leak channel, non-selective 13,80 0 
Slc6a17 
solute carrier family 6 (neurotransmitter transporter), 
member 17 12,90 0 
Nrcam neuronal cell adhesion molecule 12,82 0 
Kcnab1 
potassium voltage-gated channel, shaker-related 
subfamily, beta member 1 12,42 0 
Nrgn neurogranin 12,10 0 
Syt16 synaptotagmin XVI 11,94 0 
Cadps2 Ca2+-dependent activator protein for secretion 2 11,79 0 
Atcay ataxia, cerebellar, Cayman type homolog (human) 11,66 0 
Atxn1 ataxin 1 11,36 0 
Cacna1d 
calcium channel, voltage-dependent, L type, alpha 1D 
subunit 11,29 0 
Negr1 neuronal growth regulator 1 11,18 0 
Gabrb3 
gamma-aminobutyric acid (GABA) A receptor, subunit 
beta 3 11,13 0 
Npas2 neuronal PAS domain protein 2 10,59 0 
Pclo piccolo (presynaptic cytomatrix protein) 10,33 0 
Cadps Ca2+-dependent secretion activator 9,94 0 
Ncdn neurochondrin 9,55 0 
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Symbol Description 
Fold 
expression 
over NSC 
q-value 
(%) 
Mdk midkine 9,15 0 
Scg3 secretogranin III 8,89 0 
Elavl3 
ELAV (embryonic lethal, abnormal vision, Drosophila)-
like 3 (Hu antigen C) 8,87 0 
Ntrk2 neurotrophic tyrosine kinase, receptor, type 2 8,77 0 
Kcna1 
potassium voltage-gated channel, shaker-related 
subfamily, member 1 8,77 0 
Elavl2 
ELAV (embryonic lethal, abnormal vision, Drosophila)-
like 2 (Hu antigen B) 8,69 0 
Kcnf1 potassium voltage-gated channel, subfamily F, member 1 8,46 0 
Cacng2 calcium channel, voltage-dependent, gamma subunit 2 7,99 0 
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Table 2. PCR oligo sequences. Related to Experimental Procedures.       
           
MOUSE GENE For Rev 
18S rRNA TGTCTCAAAGATTAAGCCATGC GCGACCAAAGGAACCATAAC 
AmotL2 GCAAGGGCTCGTATCCAGTG CGTCTCTGCTGCCATGTTTG 
Amy (Amy2A) GGTTGCCTTCAGGAATGTGG GTGAGCTTTGCCATCACTGC 
AnkrD1 CTGTGAGGCTGAACCGCTAT TCTCCTTGAGGCTGTCGAAT 
Axin2 GAGATGACGCCTGTGGAACC CCTGCTCAGACCCCTCCTTT 
Axl CGAGGCCAAACTCCCTATCC GGGCAGAGCCTTCAGTGTGT 
c-Myc AGGCGGACACACAACGTCTT TGCTCGTCTGCTTGAATGGA 
Camk2a CCCTGGAATGACAGCCTTTG GAGGGTTCAGGATGGTGGTG 
CD44 GCTTGGGGACTTTGCCTCTT TGCTCAGGGCCAACTTCATT 
CD133 TGCGGACCCTCTGAATTTGT TGGGCACAGTCTCAACATCG 
Cpa1 TGACATCTCTACACGGGACCAA GCAGGCAGCAGGAAACCTCT 
Ctgf CTGCCTACCGACTGGAAGAC CATTGGTAACTCGGGTGGAG 
CyclinD1 GACCTTTGTGGCCCTCTGTG AAAGTGCGTTGTGCGGTAGC 
Cyr61 GCTCAGTCAGAAGGCAGACC GTTCTTGGGGACACAGAGGA 
Ela (CEla1) CTGGGGCTCCTCTGTGAAGA GGCTTCCTGGCGACATTACA 
Gapdh ATCCTGCACCACCAACTGCT GGGCCATCCACAGTCTTCTG 
Hes1 CCCGGCATTCCAAGCTAGAG CGTTGATCTGGGTCATGCAG 
Hey2 TGAGAAGACTAGTGCCAACAGC TGGGCATCAAAGTAGCCTTTA 
K19 AGGAGCTGAACACCCAGGTC GGGCTTCAAAACCGCTGAT 
Msi1 GTTCCAAGCCACGACCTACG AAGCCGTGAGAGGGATAGCTG 
Msi2 CAGCCGAAAGAAGTCATGTTCC TCTGCCATAGGTTGCCACAA 
Nestin CCCTGAAGTCGAGGAGCTG CTGCTGCACCTCTAAGCGA 
NeuN GCGTTCCCACCACTCTCTTG GGATCAGCAGCGGCATAGAC 
Ptf1a TCCACACTTTAGCTGTACGGATG CCAGGCCCAGAAGGTTATCA 
SNAP25 CAACTGGAACGCATTGAGGAA GGCCACTACTCCATCCTGATTAT 
Snca TGTGGCTGCTGCTGAGAAAA TCACCACTGCTCCTCCAACA 
Sox2 GCGGAGTGGAAACTTTTGTCC CGGGAAGCGTGTACTTATCCTT 
Sox9 AGGCCACGGAACAGACTCAC CCCCTCTCGCTTCAGATCAA 
Syn1 CCCACAGCCAGTCTTCATCC CGGTCCAAGGCCAGAAAGAT 
Syp GGTGGTGTTTGGCTTCCTGA AGGAGCTGGTTGCTTTTCTGG 
Syt1 CTGTCACCACTGTTGCGAC GGCAATGGGATTTTATGCAGTTC 
Thy1 GCCAACTTCACCACCAAGGA GAGGAGGGAGAGGGAAAGCA 
TuJ1 TAGACCCCAGCGGCAACTAT GTTCCAGGTTCCAAGTCCACC 
Vim CGTCCACACGCACCTACAG GGGGGATGAGGAATAGAGGCT 
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Figure 1. Hippo-YAP/TAZ pathway in organ size control 
 
(A) Schematic representation of the mammalian Hippo pathway. Adapted from 
(Piccolo et al., 2014).  
(B-C) Overexpression of the YAP/TAZ orthologue Yorkie leads to organ 
overgrowth in Drosophila. (B) Flies expressing a Hippo-insensitive form of 
Yorkie in the eye primordium develop enlarged, folded eyes and excess head 
cuticle (Right) compared to control (Left). Adapted from (Dong et al., 2007).  
(C) Drosophila wing imaginal discs containing multiple yorkie-overexpressing 
clones (Right) reach up to eight times the area of control wing discs (Left). 
Adapted from (Huang et al., 2005).  
(D-E) Hyper-activation of YAP/TAZ results in organ overgrowth in transgenic 
mice. (D) Salvador knockout murine neonate hearts display cardiomegaly (Right) 
compared to wild-type controls (Left); ra, right atrium; la, left atrium; rv, right 
ventricle; lv, left ventricle. Adapted from (Heallen et al., 2011).  
(E) Overexpression of YAP in transgenic mice leads to a massive increase in liver 
size (Right) compared to control mice (Left). Adapted from (Dong et al., 2007).  
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Figure 2. YAP/TAZ regulation by cell density and tissue architecture.  
As published in Mariaceleste Aragona, Tito Panciera, Andrea Manfrin, Stefano 
Giulitti, Federica Michielin, Nicola Elvassore, Sirio Dupont, Stefano Piccolo. A 
mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by 
actin-processing factors. Cell 154: 1047–1059, 2013. 
 
(A-C) High cell density leads to restriction of cell area, YAP/TAZ relocalization, and 
growth arrest.  
(A) Immortalized human mammry epithelial cells (MECs) were plated at different 
densities (3,000 cells/cm2 : “Sparse”; 15,000 cells/cm2: “Confluent”; and 75,000 
cells/cm2: “Dense”); after 2 days, cells were incubated for 1 hour with a pulse of BrdU 
to label cells undergoing DNA duplication. Top panels: Cells were fixed and 
processed for anti-BrdU immunofluorescence (αBRDU), nuceli are counterstained 
with DAPI. Right: Quantitation of proliferation measured as the percentage of BrdU-
positive cells. Data are presented as mean + SD. Overt growth arrest occurs only when 
cells are plated as dense cultures. Treatment with YAP/TAZ siRNAs (siY/T) shows 
that proliferation in these cells is YAP/TAZ dependent.  (B) MECs were plated as in A 
and stained for immunofluorescence with anti-YAP/TAZ antibody (αYAP/TAZ). 
TOTO3 is a nuclear counterstain. Scale bar, 20 µm. Right: Quantification of the 
proportion of cells displaying preferentially nuclear YAP/TAZ localization (N, black), 
even distribution of YAP/TAZ in nucleus and cytoplasm (N/C, gray), or cytoplasmic 
YAP/TAZ (C, white). YAP/TAZ are strongly excluded from the nucleus in the 
majority of cells only when MECs are plated as a densely packed monolayer. (C) Cells 
in a dense monolayer display less YAP/TAZ transcriptional activity than cells in a 
confluent monolayer. MECs were plated as in A. Real-time PCR analysis of the 
YAP/TAZ target genes CTGF (purple), CYR61 (yellow) and ANKRD1 (violet) is a 
read-out of YAP/TAZ activity. Target gene levels are relative to GAPDH expression. 
(D-E) Restricting cell-substrate adhesion area to levels comparable to those of dense 
cells is sufficient to cause YAP/TAZ nuclear exclusion and inhibition of proliferation. 
MECs were seeded as individual cells plated on fibronectin-coated glass (Large) or on 
square microprinted fibronectin islands of 300 µm2 (Small). In D, cells were fixed 
after 1 day for immunofluorescence with anti-YAP/TAZ antibody (αYAP/TAZ). 
DAPI is a nuclear counterstain. Scale bar, 20 µm. Bottom panel: YAP/TAZ 
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nucleo/cytoplasmic localization was scored as in B. In E, cells were processed for 
BrdU incorporation to quantify cell proliferation as in A. Data are presented as mean + 
SD. 
(F-G) Stretching of an epithelial monolayer overcomes YAP/TAZ inhibition and 
growth arrest in contact-inhibited cells.  
(F) A monolayer stretching device was employed to reproduce some of the mechanical 
challenges experienced by tissues. MECs were seeded on the upper surface of a 
PDMS substrate to obtain a dense monolayer (see also A). Underneath the PDMS is a 
chamber filled with fluid (white space between the PDMS and glass). At atmospheric 
pressure (Dense, p = 0), the cell monolayer remains flat; when pressure is applied to 
the fluid inside the chamber (Stretched, p > 0), the increase of the chamber volume 
causes a corresponding increase of the surface to which the monolayer is attached. 
Left: After 2 days, cells were subjected to 6 hours of static stretching, fixed with the 
device still under pressure, and then processed for immunofluorescence with anti-
YAP/TAZ antibody (αYAP/TAZ). DAPI is a nuclear counterstain. Scale bar, 20 µm. 
Right: Proportion of cells displaying preferentially nuclear YAP/TAZ localization (N, 
black), even distribution of YAP/TAZ between the nucleus and the cytoplasm (N/C, 
gray), or prevalently cytoplasmic YAP/TAZ (C, white). Stretching of the epithelial 
monolayer is sufficient to partially rescue YAP/TAZ nuclear localization. Similar 
results were obtained after 3 hr of stretching (not shown). (G) MECs were plated on 
the stretching device as described in F. Left: After 2 days, cells were subjected to 6 
hours of static stretching in the presence of BrdU to label cells undergoing DNA 
duplication. Scale bar, 20 µm. Right: Quantitation of proliferation measured as the 
percentage of BrdU-positive cells. Data are presented as mean + SD. Stretching of the 
epithelial monolayer is sufficient to partially rescue cell proliferation.  
(H-I) F-actin-capping and -severing proteins are YAP/TAZ inhibitors.  
(H) A loss-of function screening identifies Capz, Cofilin and Gelsolin as YAP/TAZ 
inhibitors. An siRNA screen for 62 known negative regulators of the F-actin 
cytoskeleton was set up. MECs were transfected with two independent couples of 
siRNAs against each gene. The day after transfection, cells were replated as single 
cells on a soft ECM hydrogel (0.7 kPa) and harvested after 2 more days for qRT-PCR 
analysis of the endogenous target CTGF, to assess YAP/TAZ transcriptional activity.  
Results of the screening are presented as points of the purple line, where each point 
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corresponds to a single siRNA/gene. The orange diamonds indicate the effects of 
controls and of selected siRNAs that were further validated. Cfl, Cofilin; Gsn, 
Gelsolin. The dotted line represents CTGF levels in cells transfected with siControl 
(siCo.) but plated on a stiff ECM substrate. CTGF levels are relative to GAPDH 
expression. (I) Loss of Capzb, Cfl1 and Gsn induces formation of thicker actin 
bundles, supporting the notion that F-actin-capping and -severing proteins work 
through F-actin modification to regulate YAP/TAZ. Panels are close-up confocal 
immunofluorescence of MECs transfected with the indicated siRNAs and stained for 
F-actin with phalloidin (green) and nuclei (TOTO3, red). Scale bar, 20 µm.  
(J) Panels show representative colorimetric stacked images of BrdU incorporation, 
used to visualize spatial variations of proliferation in cell monolayers of defined shape 
and dimensions as developed by (Nelson et al., 2005). MECs were transfected with the 
indicated siRNA and were replated after 1 day as monolayers on large microprinted 
fibronectin islands (side, 500 µm). After 2 days, cells were incubated for 1 hr with a 
pulse of BrdU to label cells undergoing DNA duplication. Cells were fixed and 
processed for anti-BrdU immunofluorescence. Pictures of BrdU stainings of 50 
individual multicellular islands were turned into binary signals, superimposed to 
obtain the relative pixel frequency, and color-coded using ImageJ. A pixel value of 70 
indicates that cells at that location proliferate in 70% of the individual pictures. The 
color scale indicates the extent of cell proliferation in a given position of the 
monolayers. In control conditions the proliferation rate decreases to nearly 
undetectable levels at the center of the circle due to CIP (black/blue color), while cells 
continue proliferating along the border of the cellular sheet (green/red color). 
Depletion of CapZ rescues cell proliferation at the center of the island in a YAP/TAZ 
dependent manner. Of note, depletion of the Hippo pathway component LATS1/2 
alone cannot rescue CIP  and leaves proliferation of cells at the border still sensitive to 
inhibitors of cytoskeletal tension, whereas combined depletion of LATS1/2 and Capzb 
completely rescues contact inhibition of proliferation. 
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 Figure 3. YAP/TAZ orchestrate the Wnt response.  
As published in Luca Azzolin,  Tito Panciera, Sandra Soligo, Elena Enzo, Silvio 
Bicciato, Sirio Dupont, Silvia Bresolin, Chiara Frasson, Giuseppe Basso, Vincenza 
Guzzardo, Ambrogio Fassina, Michelangelo Cordenonsi, Stefano Piccolo. YAP/TAZ 
incorporation in the beta-catenin destruction complex orchestrates the Wnt response. 
Cell 158: 157– 170, 2014. 
 
(A-C) YAP/TAZ are activated by Wnt ligand stimulation. 
(A) Confluent HEK293 cells were treated with the canonical Wnt ligand Wnt3A or 
left untreated. After 8 hours, cells were fixed for immunofluorescence with anti-YAP-
specific antibody. Wnt treatment results in nuclear accumulation of YAP protein. 
Nuclei are counterstained with DAPI. Scale bars, 20 µm. (B) HEK293 cells were 
transfected with control (lanes 1 and 2) or two independent YAP/TAZ (lanes 3 and 4) 
siRNAs and either left untreated (lane 1) or treated with Wnt3A (lanes 2–4). The panel 
represents the results of luciferase assays with the 8xGTIIC-Lux reporter, recording 
YAP/TAZ-dependent transcriptional activity. Wnt treatment leads to activation of the 
reporter in a YAP/TAZ dependent manner. (C) ST-2 cells were transfected with 
control (lanes 1 and 2) or two independent YAP/TAZ (lanes 3 and 4) siRNAs and 
either left untreated (lane 1) or exposed to Wnt3A (lanes 2–4). The panel represents 
qRT-PCR for the YAP/TAZ endogenous target gene Cyr61, relative to Gapdh 
expression. Wnt treatment triggers YAP/TAZ transcriptional activity. In B and C Data 
are normalized to lane 1 and presented as mean + SD. 
(D) Wnt releases YAP/TAZ from the β-catenin destruction complex. HEK293 cells 
were treated with Wnt3A and harvested at different time points as indicated. Lysates 
were subjected to IP using an antibody directed against the central scaffold component 
of the β-catenin destruction complex Axin1, or rabbit IgG as control. Co-precipitating 
proteins were visualized by western blot. YAP and TAZ proteins are integral 
components of the destruction complex in Wnt-off state; Wnt stimulation leads to 
recruitment of the destruction complex to the LRP6 transmembrane co-receptor with 
ensuing release of YAP/TAZ.  
(E-G) Depletion of destruction complex components releases YAP/TAZ from 
inhibition.  
(E-F) Representative confocal images of YAP (E) or TAZ (F) in MII cells transfected 
! 85!
with the indicated siRNAs against the destruction complex components APC or 
Axin1/2. Scale bar, 20 µm. Depletion of destruction complex components results in 
YAP/TAZ nuclear accumulation. G) qRT-PCR for the YAP/TAZ endogenous target 
gene CTGF, normalized to GAPDH expression, in MII cells transfected as in (E), in 
combination with control or YAP/TAZ siRNAs as indicated. Data are normalized to 
control siRNA-treated cells and presented as mean + SD. Depletion of destruction 
complex components triggers YAP/TAZ transcriptional activity.  
(H-I) YAP/TAZ are required for β-catenin inhibition in Wnt-off state.  
(H) Depletion of YAP/TAZ decreases the amount of the ubiquitin ligase β-TrCP 
associated with the Axin1 complex. HEK293 cells were transfected with two 
independent control (lanes 2 and 3) or two independent YAP/TAZ (lanes 4 and 5) 
siRNAs. Lysates were then subjected to IP using an anti-Axin1 antibody, and co-
precipitating endogenous proteins were detected by western blot. Lysates from Axin1-
depleted cells (lane 1) were used as specificity control. (I) YAP/TAZ depletion in 
Wnt-off state triggers β-catenin transcriptional activity. Luciferase assay using the 
TOP-FLASH reporter, recording β-catenin-dependent transcriptional activity in 
HEK293 cells transfected with control or two independent YAP/TAZ siRNAs, 
compared to the effect of Axin1/2 siRNA or Wnt3A stimulation. Bars are mean + SD. 
Treatment with β-catenin siRNAs shows that inductions are β-catenin dependent. 
(J) Model depicting the roles of YAP/TAZ as components of the destruction complex 
and β-catenin inhibitors in the WNT OFF state (left) and as Wnt transducers in the 
WNT ON state (right).  
(K) YAP and TAZ are required for Wnt-driven biological effects in the mouse small 
intestine. Mice of the genotypes Villin-CreERT2 Villin-CreERT2; Apcfl/fl, Villin-
CreERT2; Apcfl/fl; Yapfl/fl; Tazfl/fl and Villin-CreERT2; Yapfl/fl; Tazfl/fl were injected with 
tamoxifen. Panels are representative immunohistochemical stainings of the small 
intestine for the proliferation marker Ki-67 of mice with the indicated genotypes at 
day 3 or 21 after tamoxifen injection. Loss of APC induces crypt expansion associated 
with rapid demise of the animals, and these phenotypes are rescued by concomitant 
deletion of YAP/ TAZ. Note that YAP/TAZ knockout per se is inconsequential for 
normal intestinal homeostasis.  
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Figure 4. YAP/TAZ are required for the expansion of intestinal crypt 
organoids. 
 
(A) Mice of the genotype Villin-CreERT2 were injected with tamoxifen. After 3 
days, intestinal crypts and villi were explanted, and lysates were subjected to 
western blot analysis for YAP, TAZ, and E-cadherin. GAPDH serves as loading 
control. 
(B and C) YAP and TAZ are required for survival of explanted intestinal crypts. 
(B) Representative images of organoids formed by crypts explanted from Villin- 
CreERT2 or Villin-CreERT2; Yapfl/fl; Tazfl/fl and cultured ex vivo for 3 days. 
Where indicated, tamoxifen was added to the culture medium at seeding.  
(C) Quantification of the number of organoids formed by each of the samples 
depicted in (B).  
(D) Genotyping of organoids as shown in Figure 4B, confirming correct 
recombination induced by tamoxifen. 
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Figure 5. YAP/TAZ are required for the expansion of pancreatic progenitors 
as organoids. 
 
(A) Representative images of a pancreatic duct fragment growing in pancreatic 
organoid medium at the indicated times and after four passages in fresh Matrigel 
(rightmost panel). Pictures are representative of three independent experiments 
performed with four technical replicates. Scale bars, 290 µm. 
(B) Pancreatic ductal organoids (“Ducts”, bottom panels) display nuclear 
YAP/TAZ by immunofluorescence. YAP/TAZ are not detected in pancreatic acini 
(top panels). Scale bar, 80µm.   
(C) qRT-PCRs for the known YAP/TAZ targets genes Axl, Ctgf, AmotL2 and 
AnkrD1 in primary pancreatic acini and pancreatic ductal organoids (mean + s.d). 
Results are representative of three independent experiments performed in 
triplicate. Data were normalized to 18S rRNA expression. 
(D) Ducts were derived from wild-type (wt) or Yapfl/fl; Tazfl/fl mice and, during 
passaging at the single cell level, transduced with Ad-Cre or Ad-GFP as control. 
Panels are representative images of resulting outgrowths. Scale bars, 70 µm. 
(E) Quantifications of the number of outgrowths formed by the indicated cells, 
treated as in D.  
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Figure 6. YAP/TAZ are genetically required for the expansion NSCs ex vivo. 
 
(A) Representative confocal images of NSCs (plated as monolayer) and neurons, 
co-stained for YAP/Nestin or TAZ/Nestin and YAP/TuJ1 or TAZ/TuJ1, 
respectively. Nuclei were stained with DAPI. Scale bar: 23 µm.  
(B) qRT-PCRs for the known YAP/TAZ targets genes Axl, Cyr61 and AmotL2 in 
neurons and NSCs (mean + s.d). Results are representative of three independent 
experiments performed in triplicate. Data were normalized to Gapdh expression. 
(C) Representative images of neurospheres from wild-type (wt) or Yapfl/fl; Tazfl/fl 
NSCs transduced with Ad-Cre. Scale bar, 250 µm. 
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Figure 7. YAP converts pancreatic acinar cells to duct-like organoids. 
 
(A) Schematic representation of the experiments performed with pancreatic acinar 
explants. Pancreatic acini were isolated from R26-rtTA; tetO-YAP S127A mice and 
seeded as whole acini in collagen (see Experimental procedures). Acinar cells 
were cultured in the presence of doxycycline until primary organoids appeared. 
Organoids obtained from these culture conditions were then passaged in fresh 
Matrigel in the absence of doxycycline every 10 days.  
(B-C) Serial images of a whole acinus derived from R26-rtTA; tetO-YAPS127A 
growing as cyst-like organoid at the indicated time points (B) after doxycycline 
addition and after one or four passages in fresh Matrigel (C) in the absence of 
doxycycline. Scale bars, 70 µm in B; 290 µm in C. 
(D) Quantification of the ability of whole acini to form ductal organoids upon 
transgenic YAP overexpression as in B. Data are presented as mean + s.d. and are 
representative of five independent experiments, performed with four technical 
replicates. 
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Figure 8. Lineage tracing and single cell gene expression profiling of acinar 
cell cultures. 
 
(A) Schematic representation of the experiments performed with lineage-traced 
pancreatic acinar explants. Pancreatic acini were isolated from Ptf1a-CreERTM; 
R26-LSL-rtTA-IRES-EGFP; tetO-YAPS127A mice and seeded as whole acini in 
collagen (see Experimental procedures). Acinar cells were cultured in the 
presence of doxycycline until primary organoids appeared. Organoids obtained 
from these culture conditions were then passaged in fresh Matrigel in the absence 
of doxycycline every 10 days.  
(B) Panels are bright field and GFP-fluorescence pictures of Ptf1a-CreERTM; 
R26-LSL-rtTA-IRES-EGFP; tetO-YAPS127A ductal progenitors, at the indicated 
passage of organoid culture, showing that no endogenous pancreatic progenitor is 
labeled by the genetic lineage tracing strategy employed. Scale bar, 290 µm. 
(C) Negative control of the experiment shown in D-E . Panels are bright field and 
GFP-fluorescence pictures of Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP; tetO-
YAPS127A exocrine acini, at the indicated time points in absence of doxycycline 
treatment (Negative controls). Scale bar, 33µm. 
(D,E) Lineage-tracing experiments using the Ptf1a-CreERTM driver. Panels are 
bright field and GFP-fluorescence pictures of transgenic YAP-expressing 
exocrine acini derived from Ptf1a-CreERTM; R26-LSL-rtTA-IRES-EGFP; tetO-
YAPS127A mice, at the indicated time points of doxycycline treatment (D) and after 
passaging in absence of doxycycline in fresh Matrigel (E). Scale bars, 33 µm in 
D; 70 µm in E. 
(F) Single cell gene expression profile of pancreatic cultures of the R26-rtTA; 
tetO-YAPS127A genotype during the YAP-induced conversion of acinar cells to 
yDucts. day 0 = starting acini (without doxycycline); day 2 = cultures that have 
experienced 48 hours of doxycycline; day 4 = cultures that have experienced 96 
hours of doxycycline. Heatmap represents expression levels as log2ratio 
normalized to 18S-rRNA. Rows are evaluated genes and columns are individual 
cells. 
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Figure 9. Characterization of yDucts 
 
(A) qRT-PCRs for the indicated exocrine and Ductal/progenitor markers in fresh 
pancreatic acini, yDucts and Ducts. Data are normalized to 18S rRNA expression 
and are referred to Acini for exocrine differentiation markers, and to Ducts for 
Ductal/progenitor genes (each set to 1). Results are representative of four 
independent experiments performed in triplicate. Data are presented as mean + 
s.d. 
(B) Organoids from duct fragments (Ducts, bottom panels) and YAP-induced 
organoids (yDucts, middle panels) expressed the ductal marker SOX9 and were 
negative for the exocrine marker Amylase (data not shown), by 
immunofluorescence. Acinar cells (top panel) are shown as control. Scale bar, 80 
µm.  
(C) Unsupervised hierarchical clustering of gene expression profiles in acini, 
yDucts and Ducts. Each column represents one separated biological sample. 
Genes are ordered according to the decreasing average expression level in acini. 
Representative genes upregulated in acinar cells (red) or in Ducts and yDucts 
(green) are on the left. 
(D) Representative immunofluorescences for the ductal marker K19 and the 
exocrine marker CPA1 before (day 0) and after yDuct differentiation (day 8). 
Similar results were obtained with organoids from normal ducts (not shown). 
Scale bars:19 µm (day 0), 16 µm (day8). 
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Figure 10. YAP converts neurons in neural stem cell-like cells. 
 
(A) Representative confocal images of cortical neurons, co-stained for 
Synaptophysin/Tau, showing that primary neurons were extensively decorated by 
synaptic structures. Scale bars, 15 µm - top panels, 5.8 µm - bottom panels. 
(B) Schematic representation of the experiments performed with hippocampal or 
cortical neurons. Primary mouse neurons were infected with lentiviral vectors and 
subsequently subjected to AraC selection for post-mitotic cells for 1 week (See 
Experimental procedures). After 15 days of doxycycline treatment in NSC 
medium, YAP-expressing neurons formed floating spheres that could be passaged 
multiple times in absence of doxycycline.   
(C) Representative images of yNSCs neurospheres (second passage, P2) derived 
from hippocampal (top panels) or cortical neurons (bottom panels). Images from 
negative control transduced neurons (rtTA/EGFP and rtTA/YAPS94A for 
hippocampal or rtTA/EGFP for cortical neurons, respectively) are shown as 
negative controls. Neurospheres from native NSCs are presented as comparison. 
Scale bars, 210 µm. 
(D) P1 yNSCs were dissociated to single cells and replated at clonal density for 
neurosphere formation in the absence of doxycycline for further passages (P2, P3, 
P4). Graphs are quantifications of neurospheres formed by the indicated cells. 
Native NSCs are presented as comparison. Results are representative of at least 8 
(P2), 6 (P3) and 3 (P4) independent experiments performed in six replicates. Data 
are presented as mean + s.d. 
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Figure 11. Lineage tracing experiments showing that yNSCs originate from 
terminally differentiated neurons. 
 
(A) Schematic representation of the genetic lineage tracing strategy used to trace 
neurons ex-vivo. 
(B) Quantifications of the percentage of Syn1-Cre traced neurons positive for the 
indicated markers (as quantified by counting the number of cells positive for each 
marker by immunofluorescence analyses). 
(C) tdTomato fluorescence and immunostaining for the indicated markers in cortical 
neurons obtained from Syn1-Cre; R26-CAG-LSL-tdTomato mice. tdTomato-positive 
neurons were also positive for the neuronal markers TuJ1, NeuN and Tau, but negative 
for the progenitor markers Nestin, Vimentin and Mash1 and for the proliferation 
markers EdU and Ki67 (see also quantifications in B). Scale bar, 19 µm. 
(D) Immunofluorescence for the synaptic markers Synaptophysin and SV2a in 
neurons derived from Syn1-Cre; R26-CAG-LSL-tdTomato mice. Scale bars, 11 µm 
(upper panels) and 5.7 µm in magnifications (lower panels). 
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Figure 12. Lineage tracing and characterization of the early stages of neuronal 
reprograming. 
 
(A) Time-course experiment with cortical neurons from Syn1-Cre; R26-CAG-LSL-
tdTomato mice, showing pictures of the same field of genetically-traced neurons taken 
at the indicated time points during YAP-induced reprogramming (top panels). Bottom 
panels are bright field (insets) and tdTomato-fluorescence pictures of yNSCs derived 
from genetically lineage-traced neurons (at the indicated passages). Neurospheres 
from Syn1-Cre; R26-CAG-LSL-tdTomato NSCs are presented as negative control.  
(B) Immunofluorescence for the indicated markers during the conversion of Syn1-
Cre/tdTomato-traced YAP-expressing neurons (day 0) to yNSCs (day 2*; * means that 
the experiment was done in the presence of the anti-mitotic drug AraC).  
(C) Quantifications of the percentage of td-Tomato-positive/YAP-expressing cells 
stained positive for the indicated markers, as in B.  
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Figure 13. Characterization of yNSCs. 
 
(A) Immunofluorescence for the indicated markers in neurons and established yNSCs 
plated as monolayer. Endogenous NSCs serve as positive control. yNSCs lost the 
expression of the neuronal markes TuJ1, Tau and NeuN and acquired the expression 
of NSC markers Vimentin, Nestin and SOX2. Scale bar, 23 µm. 
(B) Unsupervised hierarchical clustering of gene expression profiles in cortical 
neurons, yNSCs and NSCs. Each column represents one separated biological 
sample. Genes are ordered according to the decreasing average expression level 
in neurons. Representative genes upregulated in neurons (red) or in NSCs and yNSCs 
(green) are on the left. See also Table 1 for a full list of genes upregulated in neurons. 
(C) qRT-PCRs for the indicated neuronal and neural stem cell markers in neurons, 
yNSCs and NSCs. Data are normalized to Gapdh expression and are referred to 
neurons for neuronal genes, and to NSCs for neural stem cell markers (each set to 1). 
Results are representative of at least three independent experiments performed in 
triplicate. 
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Figure 14. yNSCs display tripotent differentiation potential.  
 
(A) YAP-induced yNSCs, and endogenous NSCs as positive control, were plated and 
differentiated toward an astrocytic, a neuronal or an oligodendrocytic fate (see 
Experimental procedures). Panels represent confocal images for the astrocytic marker 
GFAP (left panels), neuronal differentiation markers TuJ1 and Tau (middle panels) 
and the oligodendrocytic marker CNPase (right panels). Results are representative of 
three independent experiments performed in triplicate. Scale bars, 50 µm. 
(B) These refer to Figure 14A. By immunofluorescence, neurons differentiated from 
yNSCs werre TuJ1-positive or Tau-positive but were negative for Nestin. Scale bars, 
9µm. 
(C-G) yNSCs were transduced with a constitutive EGFP-expressing vector and 
injected in the brains of recipient mice. Four weeks later, brains were fixed and 
processed for immunofluorescence analyses. C) Panels are representative confocal 
images showing that injected cells (GFP-positive) lost expression of the NSC marker 
Nestin. A field of the subventricular zone (SVZ) of the same brain sections is shown 
as positive control of the anti-Nestin antibody staining. D-E) Panels are representative 
confocal images showing that injected yNSCs (GFP-positive) integrate in the brain 
parenchyma and massively differentiate into an astrocytic fate, as indicated by GFAP 
expression (arrows). V3 = third ventricle; TH= thalamus. F) Panels are a 
representative image showing that injected yNSCs (GFP-positive) migrated away from 
the graft and partly colonized the neuronal hippocampal area CA1; HPF= hippocampal 
formation. G) Panels are representative confocal images showing that injected yNSCs 
(GFP-positive) differentiated in NeuN- and TuJ1-positive neurons (arrows) or 
CNPase-positive oligodendrocytes. Scale bars in C,E,G, 19 µm. 
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